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ABSTRACT
The thymus supports and guides the generation of a diverse repertoire of mature T
cells from precursors derived from the bone marrow. In addition to conventional CD4
and CD8 T cells, innate-like T cells also develop in the thymus and share features of the
adaptive and the innate immune system. These ‘unconventional’ T cells have emerging
roles in tissue homeostasis and disease, but the molecular mechanisms underpinning their
development remain elusive. In this study, we uncovered the roles of the molecules
RAPTOR and PTEN in the thymic development of unconventional T cells. Capitalizing
on genetic deletion of RAPTOR, we found RAPTOR-dependent mTORC1 signaling
couples microenvironmental cues with metabolic programs to orchestrate the reciprocal
development of two fundamentally distinct T cell lineages: αβ and γδ-T cells. Loss of
RAPTOR impaired αβ but promoted γδ-T cell development while disrupting metabolic
remodeling of oxidative and glycolytic metabolism. Mechanistically, we identified
mTORC1-dependent control of reactive oxygen species (ROS) production as a key
metabolic signal that, upon perturbation of redox homeostasis, impinges upon T cell fate
decisions. Additionally, we showed that PTEN acts as a cell-intrinsic molecular brake for
the thymic development of interleukin-17 (IL-17)-producing unconventional T cells. Loss
of PTEN gave rise to a heterogeneous population of IL-17-producing thymocytes that
included invariant natural killer T cells (iNKT17), mucosal-associated invariant T cells
(MAIT17), and other unconventional T cell populations. Mechanistically, the
mTORC2/FoxO1 signaling axis converged with the IL-23/STAT3 signaling pathway to
mediate RORJt-dependent development of type 17 unconventional thymocytes in the
absence of PTEN. Collectively, these results establish mTORC1-driven metabolic
signaling as a fundamental mechanism underlying thymocyte lineage choices and
uncover PTEN as a cell-intrinsic molecular brake for the development of thymic-resident
IL-17-producing unconventional T cells.
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CHAPTER 1.

INTRODUCTION

Overview
The immune system protects the body against pathogens, harmful substances, and
cancerous cells. The two arms of the immune system, the innate and the adaptive, are
comprised of heterogeneous populations of cells with distinct physiological functions and
metabolic requirements (Figure 1-1). T-lymphocytes play a central role in adaptive
immunity. Upon maturation in the thymus, naïve T cells re-circulate through the blood,
lymphatic systems, and peripheral lymphoid organs (Surh and Sprent, 2008). After
encountering antigen presenting cells (APC) bearing cognate antigen, and in the presence
of proper co-stimulation, naïve T cells become activated and rapidly engage in metabolic
remodeling to meet the demands of rapid proliferation and effector molecule production
(Chang and Pearce, 2016). It is now well established that changes in the activation state
of T cells are coupled to distinct metabolic profiles, which in turn control T cell function
(Chapman et al., 2020).
Within the family of T cells, two fundamentally distinct lineages exist: alpha beta
(DE and gamma delta (JG T cells. These T cell lineages develop from the same bone
marrow-derived precursors in the thymus but diverge in their developmental trajectories
after undergoing T cell receptor (TCR) rearrangement (Ciofani and Zuniga-Pflucker,
2010). The TCRJG-bearing T cells are considered unconventional in part due to the
limited repertoire of TCRs they express, which is in contrast to the highly polyclonal
TCR repertoire of DE-T cells (Pasman and Kasper, 2017). In addition to JG-T cells, a
number of TCRDE-bearing lymphocytes are also considered unconventional as they too
have limited TCR repertoires and share features of the innate immune system; these
include, among others, invariant natural killer T cells (iNKT) and mucosal-associated
invariant T cells (MAIT) (Godfrey et al., 2015).
Unconventional T cells are emerging as key players in diseases and tissue
homeostasis, yet the precise molecular mechanisms underpinning their development
remain elusive (Godfrey et al., 2015; Lantz and Legoux, 2019; Lezmi and Leite-deMoraes, 2018). Additionally, and despite seminal advances in the field of
immunometabolism, knowledge remains limited in terms of the role metabolic signaling
plays in T cell lineage decisions and, in particular, the development of unconventional T
cells. Hence, the main goal of this study was to unravel molecular and metabolic
signaling mechanisms associated with the thymic development of unconventional T cells.
Cellular Players of the Immune System
All cells of the immune system develop from pluripotent hematopoietic stem cells
that reside in the bone marrow (Figure 1-1). These pluripotent stem cells divide into two
sets of common progenitors that together give rise to two distinct lineages of white blood
cells, the myeloid and the lymphoid lineages (Bhandoola and Sambandam, 2006).
1

Figure 1-1. Simplified schematic of the cells of the immune system.
Pluripotent hematopoietic stem cells give rise to all cells of the immune system. In the
bone marrow, these pluripotent stem cells divide into common lymphoid progenitors,
which produce the lymphoid lineage, and common myeloid progenitors, which give rise
to the myeloid lineage. The lymphoid lineage is comprised of natural killer (NK) cells
and T- and B-lymphocytes, whereas the myeloid lineage includes neutrophils, basophils,
mast cells, eosinophils, monocytes, dendritic cells, and macrophages.

2

Common myeloid progenitors (CMP) produce the majority of the innate immune
cells, which constitute the first line of defense of the immune system (Akashi et al., 2000;
Pronk et al., 2007). Though depicted as one single cell progenitor in Figure 1-1 for
simplicity, CMPs represent several different cells that are transcriptionally primed to give
rise to defined myeloid cell populations (Paul et al., 2016; Perie et al., 2015).
Common lymphoid progenitors (CLP), on the other hand, give rise to the antigenspecific lymphocytes of the adaptive immune system — the more specialized arm of the
immune system (Kondo et al., 1997). CLPs are also responsible for producing natural
killer (NK) cells, which are considered members of the innate immune system given that
they lack antigen-specificity (Fathman et al., 2011). Like CMPs, CLPs are highly
heterogeneous in both function and phenotypic features (Jensen et al., 2016). Challenging
evidence to the model of an absolute initial bifurcation of the myeloid and lymphoid
lineages have highlighted the complexity, heterogeneity, and flexibility of the progenitors
that allow for the establishment of the immune system (Adolfsson et al., 2005; Bhandoola
and Sambandam, 2006; Jensen et al., 2016; Katsura, 2002).
Innate Immune Cells
Cells of the innate immune system, such as macrophages, neutrophils, basophils,
and mast cells, respond rapidly to recognition of non-self signatures via signaling of
germline-encoded receptors. Pattern recognition receptors (PRRs) grant these cells with
the capacity to recognize nearly all non-self signatures while relying on a limited number
of invariant receptors (Pasman and Kasper, 2017). These receptors recognize pathogenassociated molecular patterns (PAMPs), which are simple molecules and regular patterns
of molecular structures unique to microbes (Gong et al., 2019). In this sense, the response
of innate immune cells to pathogens is immediate and with no memory.
Adaptive Immune Cells
There are two major types of adaptive immune cells, namely conventional DE-T
cells and B cells. Both are highly specialized white blood cells that express antigenspecific receptors: the T cell receptor (TCR) and the B cell receptor (BCR), respectively.
Conventional DE-T cells use their TCR to recognize peptide antigens presented by cellsurface proteins of the major histocompatibility complex (MHC) (Neefjes et al., 2011). B
cells, on the other hand, recognize antigens both in solution and on the surface of antigenpresenting cells (APCs) via their BCR (Pierce and Liu, 2010). Both cell types mount
delayed immune responses that increase in kinetic speed and response amplitude upon
antigen re-exposure, as a consequence of memory formation (Pasman and Kasper, 2017).
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Conventional DE-T Cell Development
T cells develop in the thymus from migrant precursors that originate in the bone
marrow or the fetal liver (Shortman and Wu, 1996; Zuniga-Pflucker and Lenardo, 1996).
Upon entering the thymus, these immature cells undergo a differentiation program that
can be followed by changes in cell-surface marker expression, proliferation status, and
functionality. It is now well appreciated that the integration of both intrinsic and extrinsic
signals, mediated by downstream TCR signaling and the interaction of T cell precursors
with thymic stromal cells and other neighboring thymocytes, respectively, control thymic
development (Ciofani and Zuniga-Pflucker, 2010; Yang et al., 2018).
The thymus is located above the heart, and it consists of multiple lobules. These
lobules have a well-defined cellular architecture that provides discrete cellular
microenvironments to support T cell maturation (Anderson et al., 2006; Kondo et al.,
2019). Specialized stromal cells, better known as thymic epithelial cells (TECs), form the
clearly defined cortical and medullary regions of the thymus (Breed et al., 2018). These
regions are populated by developing thymocytes that migrate from the outer cortical
region into the inner medulla region in a chemokine-dependent manner as they progress
through development (Hu et al., 2015; Kwan and Killeen, 2004; Ueno et al., 2004).
The development of TCRDE+ cells is characterized by the ultimate expression of
either CD4 or CD8 coreceptors, and the process can be followed by the coordinated
surface expression of these coreceptors (Figure 1-2). Thymic lymphoid progenitors begin
their developmental journey as part of the immature CD4–CD8– double-negative (DN)
precursor subset (Ciofani and Zuniga-Pflucker, 2006). This DN stage can be further
subdivided into four major subsets (DN1–4) based on surface expression of the D-chain
of the IL-2 receptor (CD25) and the adhesion molecule CD44, as shown in Figure 1-2
(Godfrey et al., 1993).
DN1 cells lack CD25 expression, but express CD44. They are the most immature
thymocytes, which have multi-lineage potential for the development of B cells, T cells,
myeloid cells, NK cells, and dendritic cells (DC) (Ardavin et al., 1993; Matsuzaki et al.,
1993; Shortman and Wu, 1996). DN2 cells express both CD25 and CD44, and constitute
the next developmental stage of T cells; these cells lack B cell potential, but they are still
able to develop into T cells, NK cells, and DCs (Schmitt et al., 2004; Wu et al., 1996).
The DN3 stage (CD4–CD8–CD25+CD44–) represents a key phase of T cell development
as it is at this period when thymocytes undergo TCR rearrangement, hence marking the
final commitment to the T cell lineage (Capone et al., 1998; Ismaili et al., 1996). DN3
cells that successfully complete TCRE rearrangement lose CD25 expression and become
DN4 (CD4–CD8–CD25–CD44–) cells. Survival and proliferation signaling pathways then
get activated as the cells undergo differentiation into CD4+CD8+ double-positive (DP)
cells (Zeng et al., 2007). In the process of becoming DP cells, developing thymocytes
rapidly transit through an immature CD8+ single-positive (ISP) stage that is followed by
the cell-surface appearance of the CD4 coreceptor (Robey and Fowlkes, 1994). DP cells
then lose expression of one of the coreceptors to become either CD4+ or CD8+ singlepositive T cells.
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Figure 1-2. Stages of JG and DE-T cell development.
Simplified schematic of the developmental stages that JG and DE-T cell progenitors
undergo in the thymus. Commonly used surface markers for the characterization of such
developmental stages are shown underneath each cell group.
Modified with permission of AAAS. Yang, K.*, Bastardo Blanco, D.*, Chen, X.*, Dash,
P., Neale, G., Rosencrance, C., Easton, J., Chen, W., Cheng, C., Dhungana, Y., KC, A.,
Awad, W., Guo, X., Thomas, P., Chi, H. (2018). Metabolic signal directs the reciprocal
lineage decisions of ab and gd T cells. Science Immunology 3. (* Co-first authors). DOI:
https://doi.org/10.1126/sciimmunol.aas9818.
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Depending on their maturation stage, two major signaling pathways control the
development of T cells: NOTCH and TCR. As early DN cells do not express a TCR, they
proliferate and differentiate in a TCR-independent, NOTCH-dependent manner (Yui and
Rothenberg, 2014). NOTCH receptors are large single-pass type I transmembrane
glycoproteins involved in the regulation of many aspects of metazoan development and
tissue renewal (Kopan and Ilagan, 2009). Four NOTHC receptors have been identified in
mammals (NOTCH1–4), of which NOTCH1 has been established to be both necessary
and sufficient to drive T cell development (Pui et al., 1999; Radtke et al., 1999). In terms
of NOTCH ligands, two families have been reported to exist in mammals: Delta-like
(DL) and Jagged (Kopan and Ilagan, 2009).
Following successful TCR gene rearrangement, survival and differentiation of
developing thymocytes become TCR-dependent, and NOTCH signaling gets
downregulated (Yui and Rothenberg, 2014). The process of TCR rearrangement is briefly
described next.
TCR Rearrangement
Expression of the D-, E-, J-. and G-chains of the TCR, which combined make up
the TCRs of DE- and JG-T cells, respectively, requires recombination of the variable (V),
joining (J), and diversity (D) gene segments of the V domain of the corresponding TCR
proteins (Raulet et al., 1991; Schatz et al., 1992). This process is catalyzed by linked
recombination-activating gene 1 (RAG-1) and RAG-2 proteins (Mombaerts et al., 1992;
Shinkai et al., 1993; Shinkai et al., 1992). These lymphoid-specific proteins generate sitespecific DNA double-stranded brakes that are then repaired through the classical
nonhomologous end-joining pathway (Matthews and Oettinger, 2009). This process
ensures the generation of a diverse TCR repertoire.
The process of recombination is highly regulated and occurs at specific
developmental stages. DN1 and DN2 cells have their TCRE and TCRJ loci in germline
configuration (Godfrey et al., 1994; Wu et al., 1991). Rearrangement of the TCRE locus
of DE-T cells starts at the DN3 stage (Livak et al., 1999). In fact, DN3 thymocytes are a
mixture of small TCRE-unrearranged DN3-E (DN3a) cells and large TCRE-rearranged
DN3-L (DN3b) cells (Hoffman et al., 1996; Taghon et al., 2006). Similarly, V to J
rearrangements of the TCRJ locus occurs primarily in DN3 cells and can precede that of
TCRE (Livak et al., 1999; Petrie et al., 1995). In contrast to TCRE rearrangement,
rearrangement of the TCRD locus occurs only after thymocytes have become DP cells, at
which point they undergo positive selection (Petrie et al., 1993).
DE-T Cell Development Checkpoints
E-Selection. The first checkpoint of DE-T cell development ensures that DElineage committed thymocytes underwent proper RAG-mediated recombination and that
they express a functional TCRE-chain (Carpenter and Bosselut, 2010). This process
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requires developing thymocytes to signal through their pre-TCR, which is composed of a
properly rearranged TCRE-chain paired with a pre-TCRD along with a collection of
proteins on the cell surface (i.e. the CD3/] complex) that are involved in proximal signal
transduction (Germain, 2002). Pre-TCR signaling triggers a cascade of differentiation and
proliferation events that enables cells to undergo 6–8 rounds of cell division, after which
it triggers the rearrangement of the TCR-D locus, giving rise to the second component of
the mature DE antigen receptor (Germain, 2002). This process licenses developing
thymocytes (i.e. DN3–4 cells) to progress to the DP stage (Michie and Zuniga-Pflucker,
2002; Rothenberg and Taghon, 2005).
Positive Selection. The proliferative burst originated by the pre-TCR signals
during E-selection results in the establishment of a large pool of DP thymocytes. Despite
the fact over 80% of total thymocytes are DP cells, only 5% of them survive this stage of
development and continue their developmental process (Wang et al., 2011). This is
because, once the mature TCRDE is produced, the developing thymocytes depend on
TCR signaling for their survival (Yui and Rothenberg, 2014). The random nature of TCR
rearrangement, and the high diversity of MHC alleles, translates into most DP
thymocytes failing to productively interact with peptide:MHC ligands. Consequently,
these thymocytes die of neglect (Carpenter and Bosselut, 2010). Positive selection
rescues DP thymocytes from programmed cell death on the basis of the interaction of
their newly formed TCRDE with self-peptide bound to MHC complexes expressed on
cortical TECs (cTECs) (Ladi et al., 2006; Yui and Rothenberg, 2014).
The lifespan of DP cells during positive selection is important in shaping the TCR
repertoire of peripheral T cells (Wang et al., 2011). This is because DP cells that fail to
generate a productive TCR in their first round of rearrangement get to repeat
rearrangement of their TCRD-chain as many times as necessary until successful, or until
programmed cell death intervenes. Thus, the lifespan of a DP cell determines how many
rounds of TCRD-chain rearrangement the cell can undergo, which has repercussions on
the overall diversity of the organism’s TCR repertoire (Guo et al., 2002). A large body of
evidence supports a role for the anti-apoptotic protein Bcl-xL in the regulation of survival
of DP cells (Wang et al., 2011). In fact, several transcription factors critical for T cell
development, including TCF-1 (Xie et al., 2005), E proteins (D'Cruz et al., 2010), c-Myb
(Yuan et al., 2010), and RORJt (Sun et al., 2000), regulate survival of DP cells by means
of Bcl-xL-dependent pathways. Hence, Bcl-xL is considered the master regulator of DP
lifespan.
Positively selected DP cells mature into either CD4 or CD8 single-positive (SP)
cells, which express chemokine receptors, such as CCR4 and CCR7, that allow them to
migrate towards the medulla (Cowan et al., 2014; Hu et al., 2015; Ueno et al., 2004).
Once in the medulla, SP thymocytes encounter a third developmental checkpoint,
negative selection, which ensures T cell tolerance.
Negative Selection. Newly generated SP thymocytes are CD62LlowCD69high
semi-mature cells that are functionally incompetent and susceptible to various apoptotic
signals (Takahama, 2006). Upon arrival to the thymic medulla, these developing
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thymocytes undergo further maturation to become CD62LhighCD69low mature SP
thymocytes. The thymic medulla is a specialized microenvironment composed of
medullary thymocytes, DCs, macrophages, and medullary TECs (mTECs) (Ladi et al.,
2006). mTECs, in particular, facilitate the removal of thymocytes bearing self-reactive
TCRs by, at least in part, exposing them to tissue-specific antigens in a manner dependent
on the transcriptional factor autoimmune regulator (AIRE) (Giraud et al., 2012; Kyewski
and Derbinski, 2004). AIRE deficiency in humans causes failure to establish central
tolerance to tissue-specific antigens, resulting in autoimmune polyendocrinophatycandidiasis-ectodermal-dystrophy (Takahama, 2006). Similar autoimmune diseases have
been observed in mice with AIRE deficiency as well (Kuroda et al., 2005; Liston et al.,
2003). Thus, AIRE+ mTECs are key players in the establishment of central tolerance.
Mechanisms of Central Tolerance. T cell central tolerance eliminates strongly
self-reactive progenitors so that only weakly reactive T cells leave the thymus and
populate the lymphoid organs. Clonal deletion, defined as the apoptotic death of T cell
progenitors that have high affinity for self-antigens, is the main mechanism of negative
selection for the establishment of T cell central tolerance (Palmer, 2003). Anergy and
receptor editing also eliminate high-affinity self-reactive cells but to a lesser extent than
clonal deletion (Hogquist et al., 2005). Anergy is a state of non-responsiveness to antigen
(Hammerling et al., 1991). Receptor editing, on the other hand, refers to the process by
which binding of self-antigen during development initiates secondary antigen-receptor
gene rearrangement that results in the replacement of an autoreactive receptor by a selftolerant one (McGargill et al., 2000).
Noticeably, complete deletion of self-reactive T cells is not achieved via the
aforementioned mechanisms of central tolerance. A number of individual lymphocytes
not only seem to escape the process of negative selection, but actually require substantial
self-reactivity to carry out their function in immunity. These include natural T regulatory
(nTreg) cells, invariant natural killer T (iNKT) cells, natural CD8DD+ intraepithelial T
cells that reside in the gut (nIEL), and natural T helper 17 (nTh17) cells (Stritesky et al.,
2012). The development of these T cell populations is dependent on their interaction with
high-affinity TCR ligands along with distinct molecular factors. Though they share
common features, such as an activated/memory phenotype and regulatory function in
immunity, their developmental trajectories are distinct and they can arise at distinct
stages of T cell development (Stritesky et al., 2012).
Thymic Medulla. As alluded before, the medullary region of the thymus, along
with its cellular players, plays a key role in the establishment of T cell central tolerance.
The importance of the thymic medulla is underscored by the autoimmune diseases
observed in mutant mice that present impaired medullary characteristics. Examples of
this are REL-B deficient (Burkly et al., 1995; Weih et al., 1995), lymphotoxin-E receptor
(LT-ER)-deficient (Boehm et al., 2003; Chin et al., 2003; Zhu et al., 2007), and tumornecrosis factor (TNF)-receptor-associated factor-6 (TRAF6)-deficient (Akiyama et al.,
2005) mice. These mutant mice present disrupted thymic structure, usually characterized
by smaller medullary regions that lack mTECs; mTECs can be identified by the
expression of the lectin Ulex europaeus agglutinin 1 (UEA1) (Kadouri et al., 2019).
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Despite presenting normal positive selection, these mutant mice fail to establish central
tolerance, which results in severe inflammation and/or autoimmune disease. Interestingly,
some of these mutant mice also present defects in the development of regulatory T cell
subsets, including NKT cells and nTregs (Hogquist et al., 2005).
Of note, development of nTreg occurs in the thymic medulla (Aschenbrenner et al.,
2007; Cowan et al., 2013). High-affinity TCR ligands expressed on stromal cells in the
medulla mediate the process of agonist selection, which selects CD4+ T cell clones that
recognize self-peptide:MHC-class II complexes with medium to high affinity to
differentiate into Foxp3-expressing Tregs (Kadouri et al., 2019). Both mTECs and DCs
play important roles in this process (Cowan et al., 2013; Herbin et al., 2016; Perry et al.,
2014).
Unconventional T Cells
In addition to conventional CD4+ and CD8+ DE-T cells, which require prolonged
activation and differentiation to acquire effector function and also present great diversity
in terms of TCR repertoire, the thymus supports the development of smaller subsets of T
cells with innate-like effector functions and restricted TCRs. These so-called
‘unconventional T cells’ have an activated phenotype, which grants them with the ability
to readily produce large amounts of cytokines in response to non-cognate antigen
stimulation (Godfrey et al., 2015). In other words, they are not engaged by peptide:MHC
complexes, yet they mount relatively immediate immune responses. These
unconventional T cell subsets are conserved among mammals and include JG-T cells,
iNKT cells, MAIT cells, and CD8DD+ IELs. There are also other DE-T cells that
recognize formylated peptides presented by H2-M3, but they are not existent in humans
and are not discussed here (Legoux et al., 2017).
Broadly, the generation of unconventional T cells follows two distinct
developmental pathways. Most JG-T cells, and a small percentage of IELs and iNKT
cells, develop from CD4–CD8– DN thymocytes, whereas the majority of IELs and iNKT
cells, along with MAIT cells and nTreg cells, surge from agonist selection of CD4+CD8+
DP thymocytes (Winter and Krueger, 2019).
JG-T Cells
The first wave of T cells that appears in the thymus during fetal thymic ontogeny
is composed of JG-T cells (Chien et al., 2014). The later emergence of DE-T cells is
associated with a decrease in the relative proportion of JG-T cells, which ultimately
comprises between ~0.5% and 16% of total CD3+ cells in adult human peripheral blood.
In adult mice, the JG-lineage of T cells makes up ~1–4% of total T cells in the thymus
and the secondary lymphoid organs. JG-T cells are much more numerous in mouse
mucosal sites, however, where they can amount to be up to 40% and 70% of the
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intraepithelial lymphocytes of the intestines and the skin, respectively (Goodman and
Lefrancois, 1989; Gray et al., 2011).
Both JG and DE-T cells mount cytotoxic immune responses upon activation using
a similar set of cytokines. Though their TCRs are comparable in terms of structure and
downstream signaling pathways, they differ in their diversity and ligand recognition. JGTCRs are not MHC-restricted, which provides for a more promiscuous recognition of
ligands (Holderness et al., 2013). Thus, they can recognize and respond to
unconventional antigens, including soluble, membrane-bound, and unprocessed ligands
(Elliott et al., 1988; Rock et al., 1994; Steele et al., 2000). However, the diversity at the
TCRJ locus is limited by no D, and only a few V/J segments, plus three functional C
regions (Capone et al., 1998). In the periphery, JG-T cells have a restricted TCR diversity,
which is why they are considered semi-invariant (Hayday, 2000).
The process of DE vs. JG lineage selection is mediated by the integration of
multiple environmental signals in the thymus along with TCR-signaling strength
(Carpenter and Bosselut, 2010; Ciofani and Zuniga-Pflucker, 2010; Haks et al., 2005;
Hayes et al., 2005; Lee et al., 2014; Zarin et al., 2014). The divergence between the two
lineages occurs at the DN3 stage, when the common progenitor undergoes TCR
rearrangement of the E-, J-, and G-chains (Carpenter and Bosselut, 2010; Ciofani and
Zuniga-Pflucker, 2010).
As previously discussed, the expression of a functional pre-TCR after productive
rearrangement of the TCRE-chain, together with NOTCH signals, induces a proliferative
burst that leads to the differentiation of progenitor cells in the DE-lineage into DP cells
(Kreslavsky et al., 2012). In contrast, NOTCH signaling plays a less important role in JGT cell development, and recent studies point to TCR signaling strength as a key mediator
of JG-T lineage commitment (Haks et al., 2005; Hayes et al., 2005; Lee et al., 2014; Zarin
et al., 2014). The extracellular signal-regulated kinase (ERK), early growth response-1
(EGR1), and inhibitor of DNA binding 3 (ID3) signaling axis (ERK/EGR1/ID3) has
emerged as a key player in the determination of lineage commitment. In fact, studies have
shown that the promotion of strong signals via induction of the helix-loop-helix protein
ID3 or the mere ligand engagement by TCRJG promotes the JG-lineage fate in developing
DN3 cells (Kreslavsky et al., 2008; Lauritsen et al., 2009).
Recent studies have identified Nt5e (CD73) as a marker of JG-T cell lineage
commitment (Coffey et al., 2014). The expression of CD73 is mediated by ligand
engagement of the TCRJG (Fahl et al., 2014). It is now established that CD73-expressing
immature CD24+ DN progenitors constitute an intermediate developmental stage after
commitment but before acquisition of effector fate, whereas CD73+CD24low cells are
functionally competent JG-T cells (Coffey et al., 2014).
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Invariant Natural Killer T (iNKT) Cells
iNKT cells are a heterogeneous population of TCRDE+ T cells that recognize lipid
antigens presented by the CD1d molecule. They express an invariant TCRD-chain
(VD14-JD18 in mice and the homologous VD24-JD18 in humans) paired with a semiinvariant TCRE-chain (VE2, VE7 or VE8.2 in mice and VE11 in humans) (Mori et al.,
2016; Salio et al., 2014). Mouse iNKT cells are either CD4+ or CD4–CD8– DN, whereas
human iNKT cells also have a CD8+ subset. These subsets have slightly different
functional properties, with human DN and CD8+ iNKT cells being highly cytolytic and
capable of producing IFNJ, and CD4+ iNKT cells being able to produce both IFNJ and
IL-4 and also having immunomodulatory functions (Gumperz et al., 2002; Lee et al.,
2002). Furthermore, a subset of DN iNKT cells has been shown to produce IL-17 with
potential roles in the pathogenicity of several diseases (Michel et al., 2007; Yoshiga et al.,
2008).
The majority of iNKT cells develop from CD4+CD8+ DP cells that have randomly
rearranged their TCRD locus and generated the iNKTD-chain (Egawa et al., 2005; Gapin
et al., 2001), with the exception of a small number of iNKT cells that use an alternative
developmental pathway starting from the DN4 stage (Dashtsoodol et al., 2017). In
contrast with conventional DP precursors that are selected by MHCI/II molecules on
cTECs, iNKT cell DP precursors are positively selected by CD1d-expressing DP
thymocytes presenting self-lipids (Bendelac, 1995; Coles and Raulet, 2000). This DP-DP
interaction provides the required lipid/CD1d ligand that, in addition to co-stimulation
through members of the signaling lymphocytic activated molecules (SLAM) family of
receptors and TCR signaling, licenses the iNKT precursors to continue their
developmental process. The strong signaling provided by the TCR and SLAM receptors
leads to high expression of the transcription factor Egr2, which binds to the promoter of
Zbtb16, the gene encoding the promyelocytic leukaemia zinc finger protein (PLZF), and
positively regulates its transcription (Krovi and Gapin, 2018). These cells then transition
through an uncommitted PLZFhigh stage before diverging into the functionally distinct
iNKT1, iNKT2, and iNKT17 subsets, which are defined by the transcription factors TBET, GATA-3, and RORJt, respectively. Accordingly, these iNKT subsets have cytokine
capabilities similar to those of conventional TH1, TH2, and TH17 cells.
The overall process of iNKT cell development in the thymus can be divided into
four consecutive stages (S0–3) based on the differential expression of CD24, CD44, and
NK1.1 (Benlagha et al., 2002; Pellicci et al., 2002). The least mature iNKT cells (S0) are
CD24+. S1 iNKT cells do not express CD24 nor NKT-associated markers. S2 iNKT cells
are CD44+NK1.1– and have the capacity to leave the thymus and populate peripheral
tissues, whereas S3 iNKT cells are CD44+NK1.1+ and are mostly thymus-resident
(Berzins et al., 2006; Winter and Krueger, 2019). Thymic and peripheral iNKT effector
populations do not exchange, so a small pool of CCR7+ iNKTs cells with multipotent
capacities is responsible for the establishment of the effector subsets in the thymus
(Wang and Hogquist, 2018).
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The precise molecular mechanisms controlling iNKT cell lineage fate decisions
are still not well understood, though a network of transcriptional regulators and molecular
complexes has been identified to be important for iNKT cell development and effector
lineage choices. The mechanistic target of rapamycin complex 1 (mTORC1) has been
reported to be essential for the differentiation of iNKT1 cells (Zhang et al., 2014), while
mTORC2 is important for iNKT2 and iNKT17 differentiation (Prevot et al., 2015; Wei et
al., 2014). Emerging studies have indicated a role for the forkhead box O1 (FoxO1) in
controlling iNKT effector lineage fate decisions by promoting iNKT1 and suppressing
iNKT17 lineages (Tao et al., 2019). On the other hand, the transcriptional regulators
Runx1 (Thapa et al., 2017), NKAP (Thapa et al., 2016), and BATF (Jordan-Williams et
al., 2013; Miao et al., 2013), are all essential for the development of iNKT17 cells.
iNKT cells respond to lipid antigens of similar structure to glycosphingolipid
alpha-galactosylceramide (DGalCer) (Pasman and Kasper, 2017). Originally, the term
‘natural killer T cells’ (NKT cells) was used to refer to CD3+ T cells that co-expressed
proteins normally expressed on NK cells, such as NK1.1 (CD161) (Godfrey et al., 2004).
However, the modern definition of iNKT cells refers only to cells specific to lipid
antigens presented by CD1d molecules (Godfrey et al., 2015), which can be easily
identified via flow cytometric analysis using CD1d tetramers loaded with an appropriate
antigen ligand, such as synthetic KRN7000 or other DGalCer molecules.
In addition to iNKT cells, which are also known as type I NKT cells, there is a
second type of NKT cells that also recognize lipids presented by CD1d molecules but that
uses TCRDE-chains that do not conform with the invariant motifs used by type I NKT
cells. These type II NKT cells are known as ‘diverse NKT cells’ (dNKT) (Rhost et al.,
2012). Though dNKT cells represent a small subset of NKT cells in mice, they
outnumber iNKT cells in humans (Iwabuchi and Van Kaer, 2019).
It is important to note too that humans express four additional structurally distinct
CD1d antigen-presenting molecules: CD1a, CD1b, CD1c, and CD1e (Salio et al., 2014).
Each of these CD1 proteins present divergent antigen-binding grooves with unique
patterns of intracellular trafficking and tissue expression. These human-specific CD1
proteins are also known as group I CD1 molecules, whereas the mouse-and-human CD1d
protein makes up the group II category of CD1 molecules.
Mucosal-Associated Invariant T (MAIT) Cells
MAIT cells represent a relatively new population of unconventional T cells with
emerging roles in disease and tissue homeostasis (D'Souza et al., 2018; Xiao and Cai,
2017). They are defined by the expression of an invariant TCRD-chain (VD19-JD33 in
mice and VD7.2-JD33 in humans) associated with a limited set of VE segments (VE6, 8
in mice and VE2, 13, 22 in humans) (Tilloy et al., 1999). MAIT cells recognize antigens
in a MHCI-related protein 1 (MR1)-dependent manner, which, unlike conventional MHC
molecules, presents microbial-derived vitamin B metabolites (Huang et al., 2005).
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5-(2-oxopropylideneamino)6-D-ribitylaminouracil (5-OP-RU), an adduct of a key
riboflavin (vitamin B2) biosynthesis pathway intermediate (5-A-RU) and a glycolysis
pathway intermediate (pyruvaldehyde), is the most potent stimulatory antigen of MAIT
cells (Patel et al., 2013). The identification of a potent MAIT antigen allowed for the
development of antigen-loaded (5-OP-RU) MR1 tetramers that now serve as the golden
standard for the identification of MAIT cells, similar to DGalCer-loaded CD1d tetramers
for the identification of iNKT cells (Reantragoon et al., 2013). In contrast to the vitamin
B2-derived antigens, vitamin B9 (folate)-based MR1 ligands such as 6-formyl pterin (6FP) and its derivate acetyl 6-formylpterin (Ac-6-FP) inhibit MAIT cell activation (Yan et
al., 2020).
Despite the fact that MR1 is evolutionarily conserved among mammals, mouse
and human MAIT cells present several differences that go beyond TCR usage (Huang et
al., 2009; Moreira et al., 2017). Mouse MAIT cells tend to be CD4–CD8– DN, though
small frequencies of CD4+ and CD8+ single-positive MAIT cells also exist (Rahimpour et
al., 2015). The majority of human MAIT cells, however, are CD8+ single-positive (Yan et
al., 2020). Further, MAIT cells are rare in mice but abundant in humans. In mice, MAIT
cells are mainly found in mucosal sites, such as lungs, liver, intestine, and skin
(Constantinides et al., 2019; Lantz and Legoux, 2019), at relatively low frequencies,
whereas in humans they can amount to be up to 10% of peripheral blood T cells, 10% of
CD8+ T cells, and 50% of liver T cells (Cui et al., 2015). The discrepancies between
mouse and human MAIT cells have presented a challenge for the study of these cells in
the context of disease, particularly as it relates to infectious diseases (Moreira et al.,
2017).
MAIT cells share similar developmental trajectories with iNKT cells. In contrast
to conventional T cells, which are positively selected by cTECs, both MAIT and iNKT
precursor cells interact with fellow DP cells that express MR1 or CD1d molecules on
their surface, respectively (Seach et al., 2013). For both MAIT and iNKT cells, this DPDP interaction in the cortical region of the thymus generates CD24+CD44– committed
precursors (referred as S1 in MAIT development) that then cease to express CD24 (S2 in
MAIT development) and transition into the medullary region in a process dependent on
microRNAs (Wang and Hogquist, 2016). In the medulla, the precursors are thought to
respond to environmental cues that drive their differentiation into effector subsets (S3 in
MAIT development), but it is unknown what factors drive the polarization of MAIT cells
(Godfrey et al., 2019).
In contrast to conventional T cells and iNKT cells, there are only two MAIT
effector subsets: MAIT1 and MAIT17. These subsets produce IFN-J and IL-17 in a TBET and RORJt-dependent manner, respectively. It is unclear why MAIT cells do not
produce IL-4. However, some have argued this could be related to the intensity of the
TCR-MR1 interaction, which might not reach the threshold necessary of signaling
strength to generate IL-4-producing MAIT2 cells (Legoux et al., 2019b). The argument is
based on the observation that iNKT2 cells rely on the strongest TCR signal of all iNKT
subsets during positive selection (Tuttle et al., 2018).
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PLZF plays a key role in the maturation of effector subsets in both the MAIT and
iNKT cell lineages, though the two cell types differ in the kinetics of their PLZF
requirement. iNKT cells require PLZF during the early transitional stages of development
(i.e. S1 and S2 of iNKT development, CD24–CD44–/+NK1.1–) (Engel and Kronenberg,
2014), whereas MAIT cells require it at the effector stage (i.e. S3 of MAIT development,
CD24–CD44+) (Koay et al., 2016). PLZF controls the expression of several transcription
factors that mediate effector differentiation of MAIT and iNKT cells and that also
suppresses genes of the naïve T cell program (Mao et al., 2016). In iNKT cells, TCR and
SLAM costimulation promotes the expression of the transcription factor Egr2, which
binds the Zbtb16 promoter and, therefore, induces PLZF expression (Dutta et al., 2013;
Tuttle et al., 2018). The signaling cascade that controls PLZF expression in MAIT cells,
however, is not well understood (Legoux et al., 2019b).
The classical model of MAIT cell development, as described above, entails the
full maturation of effector subsets in the thymus that then seed the peripheral organs
according to their functional programs. But, similar to iNKT cells, a CCR7+ thymic
precursors of MAIT cells that may undergo maturation and differentiation in the
periphery was recently discovered (Wang and Hogquist, 2018). This finding has given
rise to an alternative model of development in which mature MAIT cells are resident of
the thymus and peripheral MAIT cells are derived from CCR7+ precursors that leave the
thymus in an undifferentiated stage (Lantz and Legoux, 2019).
A couple of studies have reported the absence of MAIT cells in germ-free (GF)
mice, but the underlaying mechanisms for this phenomenon was unknown until recently
(Koay et al., 2016; Treiner et al., 2003). Emerging studies have shown microbe-derived
vitamin B2 metabolites are indispensable for the development of MAIT cells, and that
these metabolites get directly transferred from mucosal sites like the gut into the thymus
(Constantinides et al., 2019; Legoux et al., 2019a). These recent observations have
highlighted a role for the microbiota in the development and establishment of T cells
targeted to mucosal tissues. Furthermore, these studies have underscored the importance
of extrinsic signals in driving the development of unconventional T cells.
Natural Intraepithelial Lymphocytes (nIELs)
Intraepithelial lymphocytes (IELs) are a heterogeneous population of T cells
resident of the gut. They are embedded in the intestinal epithelial layer, where they play
important functional roles that go from protective to regulatory in kind (Cheroutre et al.,
2011; Sheridan and Lefrancois, 2010). How IELs carry out these functions is still
debated. Two types of IELs exist: natural and induced. Natural IELs (nIELs) are the
predominant type, which express CD8DD homodimers along with TCRJG or TCRDE
(Stritesky et al., 2012); TCRDE+CD8DD+ nIELs are the most well studied kind. Induced
IELs (iIELs), on the other hand, encompasses both TCRDE+CD4+ and TCRDE+CD8DE+
memory cells generated from naïve T cells during immune responses (Cheroutre et al.,
2011).
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Multiple pathways appear to exist for the development of nIELs, including both
thymic precursors-derived and extrathymically produced (Stritesky et al., 2012). In the
thymus, post-selection IEL precursors (IELps) can be found within the CD4–CD8– DN
thymocyte population as TCRE+CD5+ cells (Gangadharan et al., 2006; Mayans et al.,
2014; McDonald et al., 2014). A recent study revealed there are two major post-selection
IELp populations in the thymus, a nascent programmed death-1-expressing (PD-1+)
population and a T-BET+ population that accumulates with age (Ruscher et al., 2017).
Though both IELp populations are capable of producing intestinal CD8DD+ IELs upon
adoptive transfer, they differ in their phenotype and usage of TCR chains. PD-1+ IELps
are enriched for self-reactive clones that are largely restricted by classical MHC
molecules and that exit the thymus in a sphingosine-1-phosphate receptor 1 (S1PR1)dependent manner. T-BET+ IELps, however, have no self-reactive T cells and include
non-classical MHCI-restricted cells that express the receptors NK1.1 and CXCR3 along
with the integrin CD103 (Ruscher et al., 2017).
mTOR Signaling Pathway
The mechanistic target of rapamycin (mTOR), formerly known as the mammalian
target of rapamycin, is an evolutionarily conserved 289-kDa serine/threonine protein
kinase involved in regulating cellular growth, survival, function, metabolism, and
differentiation (Saxton and Sabatini, 2017). It was first discovered in the early 1990s
through genetic screening of Saccharomyces cerevisiae for the identification of targets of
rapamycin, a potent natural antifungal and immunosuppressor discovered in Rapa Nui in
the early 1970s (Blenis, 2017). mTOR is now recognized as a central regulator of
immune responses that senses and integrates numerous environmental signals, including
nutrients and growth factors (Chi, 2012).
mTORC1 and mTORC2
mTOR exists in two highly conserved, large molecular complexes: mTORC1 and
mTORC2. Though they both share the same catalytic subunit mTOR, they are
distinguished by their scaffolding subunits. mTORC1 contains the regulatory associated
protein of mTOR (RAPTOR) and is sensitive to rapamycin, whereas mTORC2 has the
rapamycin-insensitive companion of mTOR (RICTOR) and is relatively insensitive to
rapamycin under short-term treatment (Zeng and Chi, 2014).
RAPTOR/mTORC1. mTORC1 consists of the catalytic subunit mTOR, the core
scaffolding components RAPTOR (Kog1) and mLST8, and the other associated
components PRAS40 and Deptor (Powell et al., 2012). mTORC1 controls multiple
important biological processes. The phosphoinositide 3-kinase (PI3K)-AKT pathway is
central for the activation of mTORC1, which integrates signaling from both transcription
factors and nutrients (Laplante and Sabatini, 2012). Upon activation, mTORC1 promotes
protein synthesis by phosphorylating the translational initiation factor 4E (eIF4E) binding
protein 1 (4E-BP1) and S6 kinase (S6K) (Hsieh et al., 2012; Thoreen et al., 2012).
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mTORC1 is considered a master regulator of quiescence exit, as it induces the expression
of transcription factors, such as c-MYC, hypoxia inducible factor 1D (HIF-1D), and sterol
regulatory element-binding proteins (SREBPs), and alters anabolic and mitochondrial
metabolism through transcriptional, translational, and post-translational mechanisms
(Chapman et al., 2020). mTORC1 also controls lipid synthesis through SREBP1/2
transcription factors and promotes de novo lipid biogenesis through peroxisome
proliferator-activated receptor J (PPAR-J)-dependent regulation (Laplante and Sabatini,
2012). mTORC1 is also involved in the regulation of cell cycling and survival by
regulating cyclin D1 and c-MYC expression (Gera et al., 2004). The activation of the
phosphatase and tensin homolog (PTEN) inhibits mTORC1 signaling by turning off PI3K
signaling via dephosphorylation of phosphatidylinositol-3,4,5-trisphosphate (PIP3)
(Shimobayashi and Hall, 2014).
RICTOR/mTORC2. mTORC2 is comprised of mTOR, RICTOR, mLST8, and
three other associated proteins, mSIN1, PROTOR, and DEPTOR. PI3K also induces
mTORC2 activity, which in turn activates AKT by phosphorylating it on serine 473
(S473) (Shimobayashi and Hall, 2014). mTORC2 signaling influences cell survival,
proliferation, growth, differentiation, and trafficking. Once activated, AKT
phosphorylates the tuberous sclerosis complex (TSC) protein 2 (TSC2), which disables
the TSC1-TSC2 complex that inhibits mTORC1. mTORC2 also contributes to
quiescence exit, in part by repressing FoxO1 signaling through activation of AKT, which
induces the expression of glucose transporter 1 (GLUT1), therefore, enhancing glycolytic
flux (Chapman et al., 2020). Additionally, AKT promotes cell proliferation by
phosphorylating the cell cycle regulatory protein p27 (Shin et al., 2002) and by indirectly
inhibiting the tumor suppressor p53 (Vousden and Lane, 2007). Protein kinase C (PKC)
and serum- and glucocorticoid-regulated kinase 1 (SGK1) are both downstream of
mTORC2 and regulate cytoskeletal dynamics and ion transport, respectively (Chi, 2012;
Zarogoulidis et al., 2014). As previously alluded, mTORC2 is insensitive to rapamycin in
short-term treatment, but can still be blocked under prolonged or high dose of rapamycin
treatment in a variety of cells, including CD4+ T cells, but not effector CD8+ T cells
(Zeng and Chi, 2014).
Regulation of mTOR Activity in T Cells
mTOR integrates a plethora of signals that drive T cell development and function.
Broadly, the activating signals of mTOR in T cells can be grouped into three categories:
immune signals, environmental cues, and nutrients (Chi, 2012). Within the immune
signals, antigen recognition by TCR induces mTOR activation via the activation of PI3K
(Exley et al., 1994). The engagement of costimulatory receptors, such as CD28, ICOS,
and OX-40, further amplifies mTOR activity (Waickman and Powell, 2012). Growth
factors and immunomodulatory factors provide environmental stimuli for the activation
of mTOR, which are typically accompanied by metabolic cues derived from nutrients
(Chi, 2012). The GTP-loaded form of the small GTPase Ras homolog enriched in brain
(RHEB) serves as a signal transducer of many of these upstream signals to mTORC1.
RHEB is regulated by the GTPase-activating protein (GAP) of the TSC1-TSC2 complex.
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The TSC complex integrates the respective positive and negative signals transduced from
the PI3K-AKT and APM-activated protein kinase (AMPK) pathways (Zoncu et al.,
2011). When this complex is phosphorylated by AKT or ERK1/2, its GAP activity is
inhibited, which allows RHEB to activate mTORC1 (Powell et al., 2012).
In comparison to mTORC1, the regulation of mTORC2 is largely understudied
and less understood (Saxton and Sabatini, 2017). Growth factors are thought to be major
players in the activation of mTORC2 and relatively recent studies have shown ribosomes
link PI3K to mTORC2 activation (Luo et al., 2018; Oh et al., 2010; Zinzalla et al., 2011).
PI3K activation by insulin or other growth factors phosphorylates PIP2 to PIP3, which
binds mSin1-PH, releasing its inhibition on the mTOR kinase domain of mTORC2 (Luo
et al., 2018).
mTOR in T Cell Development
mTOR has emerged as a central regulator of T cell function and fate that
integrates immune signals and metabolic cues (Chi, 2012). Several studies have linked
mTOR to hematopoiesis, thymopoiesis, T cell differentiation, and quiescence (Chapman
et al., 2020; Chapman and Chi, 2014). Loss of mTORC1 via conditional deletion of
RAPTOR in early thymocyte development induces developmental blockage of T
lymphopoiesis as a consequence of reduced cell cycling and proliferation, along with
increased apoptosis (Hoshii et al., 2014). Deletion of RAPTOR in later stages of T cell
development does not have major developmental consequences, however (Delgoffe et al.,
2009; Yang et al., 2013). Thus, mTORC1 differentially regulate T cell development.
Loss of mTORC2 via deletion of RICTOR has shown to be destructive of T cell
development, leading to thymic atrophy (Chou et al., 2014; Hoshii et al., 2014; Lee et al.,
2012). mTORC2-dependent regulation of T cell development differs from mTORC1, as
the former is mediated by the stabilization, de novo synthesis, and/or post-transcriptional
modification of proteins involved in thymic selection (Chou et al., 2014); these proteins
include the coreceptors CD4 and CD8, pre-TCR, TCR, NOTCH, and CD147. Emerging
studies have also unraveled critical functions of RICTOR in NOTCH-driven development
of DE-T cells (Lee et al., 2012; Tang et al., 2012). Altogether, these studies have
demonstrated discrete roles of mTORC1 and mTORC2 in thymocyte development.
mTOR and T Cell Metabolism
Metabolic remodeling of T cells is intrinsically linked to their development,
activation, function, differentiation, and survival (Geltink et al., 2018). Throughout their
lifespan, T cells engage on different metabolic programs to meet their bioenergetic
demands. Glycolysis and oxidative phosphorylation (OXPHOS) are the two main drivers
of T cell metabolism, which supply cells with the required ATP to carry out biological
processes. During glycolysis, glucose gets broken down into pyruvate, in a process that is
regulated by transcriptional, post-translational, and metabolic cues. This process has
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relatively low ATP output, but it provides cells with important metabolic intermediates
for many other metabolic pathways (Vander Heiden et al., 2009). In fact, T cells engage
in aerobic glycolysis, that is the conversion of pyruvate into lactate in the presence of
oxygen (also known as the Warburg effect), upon activation. This process is dependent
on PI3K/AKT/mTOR signals (MacIver et al., 2013; Powell et al., 2012). A recent study
further highlighted the interconnectivity of mTOR activity, glycolysis, and CD8+ T cell
effector function as it showed mTORC1 inhibition concomitantly reduces glycolytic rate
and effector functions, whereas deletion of mTORC2 enhances glycolysis and effector
functions (Pollizzi et al., 2015). Thus, mTOR plays a crucial role in T cell function by
controlling metabolic remodeling.
The generation of reactive oxygen species (ROS) in the mitochondria, or by
NADPH oxidase expressed by CD4+ T cells, has been reported to be crucial in driving
efficient and sustained aerobic glycolysis during CD4+ T cell activation (Jackson et al.,
2004; Previte et al., 2017). Experiments done with the antioxidant glutathione have
shown that lack of ROS accumulation inhibits T cell activation, in part by decreasing
mTOR and c-Myc activity (Mak et al., 2017). Furthermore, mitochondrial ROS is critical
for activation of nuclear factor of activated T cells (NFAT) and subsequent IL-2
production, both of which are drivers of T cell activation (Sena et al., 2013). Hence, ROS
has emerged as an important metabolic signal for T cell activation and function.
PTEN Signaling Pathway
The phosphatase and tensin homolog gene, Pten, is a powerful tumor suppressor
gene involved in a plethora of cellular processes, including energy metabolism (GarciaCao et al., 2012), cell motility (Tamura et al., 1998), genomic stability (Shen et al., 2007),
and epigenome architecture (Chen et al., 2014). It was discovered in 1997 and
characterized one year later as a lipid phosphatase that dephosphorylates PIP3 by
removing the 3-phosphate of the inositol ring (Brandmaier et al., 2017; Maehama and
Dixon, 1998), therefore, antagonizing the catalytic activity of PI3K. This antagonistic
function of PTEN towards the PI3K/AKT signaling pathway contributes substantially to
its polyfunctionality in cancer development, metabolism, and immunity. Nonetheless,
PTEN also has lipid phosphatase-independent functions, which are observed upon its
localization to the nucleus (Wang et al., 2015).
PTEN is one of the most commonly mutated tumor suppressors in human
malignancies (Wang et al., 2015). Complete loss of PTEN is associated with advanced
cancer and poor prognosis. Germline mutations of Pten are associated with a group of
autosomal dominant syndromes known as PTEN hamartoma tumor syndromes (PHTS),
which include Cowden disease, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related
Proteus syndrome, and Proteus-like syndrome (Hobert and Eng, 2009). These syndromes
are characterized by developmental disorders, neurological deficits, and an increased
lifetime risk of cancer.
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Regulation of PTEN
PTEN is constitutively expressed in normal tissues. Multiple molecular
mechanisms control its expression and activity, which can generate a continuum of
functional PTEN levels (Song et al., 2012).
Transcriptional Regulation. At the transcriptional level, EGR, PPARJ, and p53
are the main positive regulators of Pten gene expression (Wang et al., 2015). These
transcriptional regulators have been shown to directly bind to the Pten promoter region
(Patel et al., 2001; Stambolic et al., 2001; Virolle et al., 2001). Conversely, mitogenactivated protein kinase kinase-4 (MAPKK4), transforming growth factor beta (TGF-E),
nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-NB), insulin-like
growth factor 1 (IGF-1), the transcriptional cofactor c-Jun protooncogene, and the B-cellspecific Moloney murine leukemia virus insertion site 1 (BMI1) proto-oncogene are
negative regulators of Pten gene expression (Wang et al., 2015). Additionally, there is
evidence PTEN engages in complex crosstalk with other pathways, which suggest some
of the pathways controlled by PTEN can in turn regulate Pten transcription in a feedback
loop (Wang et al., 2015).
Post-Transcriptional Regulation. Several miRNAs have been identified as
promoters of tumorigenesis or metabolic disorders by downregulating PTEN expression.
These include miR-17~19 cluster in lymphoproliferative disease and autoimmunity, miR19 in leukemia and Cowden disease, miR-21 in multiple cancers, inflammation and
metabolic diseases, among others (Song et al., 2012).
Post-Translational Regulation. Multiple post-translational modifications,
including active site phosphorylation, ubiquitination, oxidation, and acetylation, can
regulate PTEN activity too (Wang et al., 2015). In particular, phosphorylation of PTEN
in its C-terminal tail determines the conformational state of PTEN and, therefore, its
activity status. Additional phosphorylation of PTEN in other sites can either increase or
decrease protein stability.
Protein-Protein Interactions. PTEN interacts with several proteins that
influence its protein levels, conformational status, stability, and localization (Song et al.,
2012). Additionally, PTEN has a 3-amino acid C-terminal region capable of binding PDZ
domain-containing proteins, which may control localization of PTEN and its interaction
with other proteins (Georgescu et al., 1999; Wu et al., 2000).
The PTEN/PI3K/AKT/mTOR Pathway
PTEN is the only known lipid phosphatase to antagonize PI3K activity, which is
largely what makes it such an important tumor suppressor. Loss or inactivation of PTEN
causes the excessive accumulation of PIP3 at the plasma membrane, which recruits and
activates a subset of proteins that contain plecktrins homology domains (PH domains) to
cell membranes, such as the AKT family of proteins and phosphoinositide-dependent
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kinase-1 (PDK1) (Song et al., 2012). AKT gets activated by phosphorylation at
Threonine 308 (T308) and S473 by PDK1 and mTORC2, respectively (Manning and
Cantley, 2007; Zoncu et al., 2011). Active AKT promotes cell survival, cell proliferation,
angiogenesis, and cellular metabolism by phosphorylating downstream signaling
proteins, including glycogen synthase kinase 3 (GSK3), FoxO, B cell lymphoma 2 (Bcl2)
antagonist of cell death (BAD), the E3 ubiquitin protein ligase MDM2 and p27 (Manning
and Cantley, 2007). AKT can also activate mTORC1 by phosphorylating TSC2, hence
deactivating the TSC complex, which inhibits the activator of mTORC1 RHEB (Guertin
and Sabatini, 2007). Additionally, AKT induces the inhibitory phosphorylation of the
negative regulator of mTORC1 PRAS40 (Vander Haar et al., 2007; Zoncu et al., 2011).
PTEN in T Cell Development
PTEN plays fundamental roles in T cell biology. From development to function,
PTEN is a key player in T cell-mediated immune responses. Deletion of PTEN in the T
cell compartment causes fatal defects in central and peripheral tolerance (Suzuki et al.,
2001). Mice harboring PTEN-deficient T cells suffer from mature T cell lymphomas that
arise in the thymus (Hagenbeek and Spits, 2008). Although PTEN is lost early in these
mice, thymocyte premalignancy does not start until mice are 6 weeks old, it then becomes
stronger by 9 weeks of age, followed by metastasis after 10 weeks of age, and death by
15–20 weeks of age (Liu et al., 2010b; Xue et al., 2008). Interestingly, the development
of lymphomas in the context of PTEN deficiency is mediated by developing thymocytes
only, given that deletion of PTEN in mature T cells does not cause malignant
transformation, though it still leads to severe multiorgan autoimmunity (Liu et al.,
2010b). It has been shown that absence of PTEN allows TCRDE+ lineage thymocytes to
bypass IL-7 and pre-TCR-mediated signaling, thus resulting in the survival and
expansion of thymocytes that would have otherwise been deleted during E-selection
(Hagenbeek et al., 2004). Heterozygous inactivation of Pten does not cause
tumorigenesis, but still triggers lethal autoimmune disorders that are mediated by an
impaired Fas response to activated lymphocytes, including self-reactive cells in the
periphery (Di Cristofano et al., 1999). Additionally, it has been proposed that PTEN sets
a threshold for activation that enforces the need for T cell costimulation (Buckler et al.,
2006). Absence of PTEN, therefore, allows T cells to acquire effector function and
produce proinflammatory cytokines in response to TCR signals alone. Altogether, these
studies show PTEN plays a crucial role in the maintenance of self-tolerance and has
important roles in T cell development.
Summary and Aims of Dissertation
The conserved nature of unconventional T cells highlights the importance of these
unique groups of T cells for the immune system. More and more studies are revealing
important functions for these cells in tissue homeostasis and diseases. However, the
molecular mechanisms underpinning the fate decisions of progenitor cells towards the
development of unconventional T cell lineages remain elusive. The engagement of
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discrete metabolic pathways has been demonstrated to be a determining factor in T cell
mediated-immune responses and a key player of T cell biology. Nonetheless, the study of
metabolic signaling in T cell fate choices and, in particular, in the development of
unconventional T cells has remained largely unexplored. Thus, this study was pursued
with the aim of unraveling molecular mechanisms driving the development of
unconventional T cells. In particular, the role of RAPTOR-dependent mTORC1 signaling
in T cell fate choices and PTEN-mediated control of unconventional T cell development
were explored and characterized. This work expands the field’s understanding of T cell
development and establishes metabolic signaling as a key mediator of T cell fate choices.
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CHAPTER 2.

METHODS AND MATERIALS1
Mice

C57BL/6, Rptorflox, CD45.1+, Erk2flox, Cd2-Cre, Rag1–/–, Ptenflox, Il17icre, Pten+/–,
ROSA26GFP (harboring a loxP-site-flanked STOP cassette followed by a GFP-encoding
sequence inserted into the ROSA26 locus), and Stat3flox mice were purchased from The
Jackson Laboratory. Cd4-Cre, Rictorflox, Il23–, and Foxo1flox mice have been described
previously (Cua et al., 2003; Liu et al., 2010a; Paik, 2006; Shiota et al., 2006; Yang et al.,
2011). Littermates (Cre– flox/flox and Cre+ non-floxed mice) were used as WT controls.
For experiments reported in Chapter 3, 6–10-week old mice were used unless otherwise
noted, and for experiments reported in Chapter 4, 3–6-week old mice were used unless
otherwise noted. All mice were kept in specific pathogen-free conditions in the Animal
Resource Center of St. Jude Children’s Research Hospital (SJCRH). Animal protocols
were approved by the Institutional Animal Care and Use Committee of SJCRH.
Bone Marrow Chimera
Bone marrow (BM) chimeras were generated by transferring a consistent number
of T cell-depleted bone marrow cells from donor mice into sublethally irradiated (550
rads) Rag1–/– recipient mice. At least 1.8 × 106 donor cells were transferred into recipient
mice for the generation of full BM chimeras. For mixed BM chimeras, spike
(congenitally marked CD45.1+) and donor cells (congenitally marked CD45.2+) were
mixed in a 1:1 ratio for a total of at least 5 × 106 total cells, which were then transferred
into recipient mice. BM cells were extracted from both posterior and anterior legs of mice
by flushing the bones with Hanks’ Balanced Salt solution (HBSS). Extracted cells were
then depleted of T cells by magnetic bead-based purification, using a mixture of CD4
(L3T4), CD8a (Ly-2), and CD90.2 (Thy1.2) beads in a 1:1:1 ratio. Flow-through of the
magnetic columns was then normalized for equal cell numbers across all donor samples
and retro-orbitally injected into recipient mice in 100 μL of Phosphate-buffered saline
(PBS). Baytril water was used as an antibiotic treatment for BM chimeras for three weeks
after irradiation. Proper immune system reconstitution was verified by retro-orbital
bleeding 4–6 weeks after the generation of the chimeras. Mice were analyzed 4–10 weeks
after reconstitution.
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Polymerase Chain Reaction (PCR)
PCR was used to genotype mice using primers (Invitrogen) listed on Table 2-1. A
master mix of nuclease-free water, 1× Tsg enzyme buffer, 25 mM MgCL2, 10 mM
dNTPs (all from Lamda Biotech), allele-specific primers and Tsg enzyme was prepared.
Genomic DNA purified from mouse toes, tail, or ear clips was then added to each
reaction; each set of PCR reactions also had positive and negative controls. Programs
used to run the reactions in thermal cyclers are listed on Table 2-2. To visualize the PCR
products, samples were mixed with 6× DNA loading dye (Lambda Biotech) and run in
1.5% agarose gel via electrophoresis. Bands were visualized with GelRed (biotium) on a
Gel Doc 2000 or a ChemiDoc Touch Imaging System (Biorad). Samples were scored
according to the band size listed on Table 2-1.
Single Cell Suspension
Mice were sacrificed by CO2 asphyxiation and organs (thymus, spleen, liver,
lung, Peyer’s patches, mesenteric and peripheral lymph nodes, which included inguinal,
auxiliary, and cervical lymph nodes pooled together) were harvested. Throughout all
procedures, organs were kept on ice. Unless otherwise noted, all spins were done at 2,000
RPM for 5 min at 4°C.
Thymus, Spleen, Lymph Nodes, and Peyer’s Patches
Organs were placed under 70 μm nylon mesh and gently grinded with the flat end
of a 3 mL syringe in 10 cm petri dishes containing 1 mL of wash buffer (HBSS + 2%
Fetal Bovine Serum (FBS)). The mesh was then washed with wash buffer, and cells were
collected in a 15 mL conical tube. Cells isolated from the thymus, lymph nodes, and
Peyer’s patches were used immediately for downstream assays, whereas splenocytes
were centrifuged and resuspended in 1 mL of Ammonium-Chloride-Potassium (ACK)
Lysing Buffer (Gibco) to lyse red blood cells. After 1–2 minutes at RT, the splenocytes
were washed with twice as much volume of ACK lysis buffer, centrifuged, and
resuspended in an appropriate volume of wash buffer for downstream assays.
Lung
Lungs were first padded on paper towels to dry up and then cut and minced with a
razor blade in a petri dish. Minced tissues were then transferred into a 6-well plate
containing 2–5 mL of digestion buffer (Roswell Park Memorial Institute (RPMI) buffer +
2% FBS + 1 mg/ml Collagenase IV + 0.05% DNase) and incubated at 37°C + 5% CO2
for 45 min. After digestion, samples were harvested and filtered using a 70 μm cell
strainer placed on top of a 50 mL conical tube to collect the flow-through; tissues were
smashed against the filter using the bottom of a syringe. Samples were then washed with
copious amounts of wash buffer, spun down, and resuspended in an appropriate volume
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Table 2-1.

List of primers used for PCR.

Primer Name
iCre
CreJAX
Internal control
CD4-Cre
Raptor
ERK2
Rictor
Pten
Stat3
IL23a

FoxO1

Forward Primer

Reverse Primer

AGATGCCAGGAC
ATCAGGAACCTG
GCGGTCTGGCAG
TAAAAACTATC
TGAGCTGCCCCA
AGAGAATAG
TCTCTGTGGCTG
GCAGTTTCTCCA
CTCAGTAGTGGT
ATGTGCTCA
CAGAGCCAACA
ATCCCAAAC
ACTGAATATGT
TCATGGTTGTG
CAAGCACTCTG
CGAACTGAG
CCTGAAGACCA
AGTTCATCTGT
GTGAC
CTTCCAACCCT
CCAGATCC

ATCAGCCACACC
AGACACAGAGATC
GTGAAACAGCAT
TGCTGTCACTT
GTACACTGTCTG
CATGGGACCA
TCAAGGCCAGAC
TAGGCTGCCTAT
GGGTACAGTATG
TCAGCACAG
GGCTGCAACCAT
CTCACA
GAAGTTATTCAG
ATGGCCCAGC
GAGTTAAGTTTT
TGAAGGCAAGATGC
CACACAAGCCAT
CAAACTCTGGTC
TCC
TGCAGATCACA
GAGCCAGC;
GCAGCGCATCG
CCTTCTATC
CCAGAGTCTTT
GTATCAGGCAA
ATAA;
CAAGTCCATTA
ATTCAGCACATTG

GCTTAGAGCAG
AGATGTTCTCA
CATT
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Product Length
(bp)
220
100
120-130
~300
170 (loxP)
150 (wt)
350 (mut)
278 (wt)
554 (loxP)
466 (wt)
328 (loxP)
156 (wt)
Upper band
(loxP)
238 (wt)
307 (wt)
250 (mut)
190 (KO)
149 (loxP)
115 (wt)

Table 2-2.

PCR programs used to amply genes of interest.

CreJAX
1) 94°C for 2 min
2) 94°C for 30 sec
3) 60°C for 30 sec
4) 72°C for 1 min
5) Go to 2, 31 times
6) 72°C for 5 min
7) 95°C for 5 min
8) End

iCre, CD4-Cre, Raptor,
ERK2, PTEN, Stat3, IL23a,
and FoxO1
1) 94°C for 2 min
2) 84°C for 45 sec
3) 65°C for 45 sec
-0.3°C per cycle
4) 72°C for 5 min
5) Go to 2, 36 times
6) 72°C for 5 min
7) 15°C for 5 min
8) End
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Rictor
1) 94°C for 2 min
2) 94°C for 30 sec
3) 60°C for 30 sec
4) 72°C for 1 min
5) Go to 2, 39 times
6) 72°C for 5 min
7) 15°C for 5 min
8) End

of wash buffer for downstream assays. If too many red blood cells were visible, then
samples were quickly ACK-lysed for no more than 1 min.
Liver
Livers were placed in 6-well plates and smashed using the flat bottom of a
syringe. Homogenized tissues were then digested with 5 mL of digestion buffer (RPMI +
2% FBS + 1 mg/ml Collagenase IV) for 1 h in a 37°C + 5% CO2 incubator. After
digestion, samples were harvested and transferred into 50 mL conical tubes containing 20
mL wash buffer. Tubes were vigorously mixed to loosen cells and then spun down at
100× g for 1 min. The supernatant was passed through a 70 μm cell strainer and spun
down at 600× g for 5 min. The cell pellet was resuspended in 3 mL wash buffer, and 2
mL of lymphocyte separation medium (LymphoSep, MP Biomedicals) was underlaid.
The tubes were then centrifuged at 2,500 RPM for 20 min at RT with slow acceleration
and brake (setting 3). Middle lymphocyte layer was then carefully extracted, washed with
copious amounts of wash buffer, spun down, and resuspended in an appropriate volume
of wash buffer for downstream assays.
Flow Cytometry
Flow cytometry data were acquired on LSRII or LSRFortessa (Becton Dickinson)
machines and analyzed using FlowJo software (Tree Star). Unless otherwise noted, 7Aminoactinomycin D (7AAD) or Fixable Viability Dye (FVD, eBioscience) were used to
exclude dying cells from flow cytometric analyses of freshly isolated or fixed cells,
respectively.
Surface Staining
For analysis of surface markers, cells were stained in FACS buffer (PBS
containing 2% (wt/vol) bovine serum albumin (BSA)) for 20 min at RT or for 1 h when
co-stained with tetramers. The antibodies used for flow cytometric analysis are listed on
Table 2-3. The following tetramers were used for the identification of iNKT and MAIT
cells, respectively: mouse CD1d loaded with PBS-57 and mouse MR1 loaded with 5-OPRU; both tetramers were provided by the National Institute of Health (NIH) Tetramer
Core Facility.
Intracellular Staining
For intracellular marker staining, single cell suspensions were first stained for
surface markers as described above, then washed with ice-cold FACS buffer and fixed
using fixation/permeabilization buffer (eBioscience) for at least 1 h at 4°C. After fixation
was completed, cells were washed with 1× permeabilization buffer (eBioscience) and
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Table 2-3.

List of antibodies used for flow cytometric analysis.

Antibody
Akt (pS473)
BrdU
Caspase-3, Active
CCR6 (CD196)
CCR7
CCR9
CD4
CD5
CD8D
CD24
CD25
CD44
CD45.1
CD45.2
CD62L
CD69
CD71
CD73
CD98
CD103
CD127
FoxP3
ID3
ID3
IFN-J
IL-4
IL-17$
IL-17F
Ki67
ROR gamma (t)
p-FoxO1 (Thr24)/
FoxO3a (Thr32)
p-STAT3
p-S6
p-4E-BP1
PTEN
S1P1
T-BET
TCRE
JGTCR

Clone
M89-61 (RUO)
BU20A
C92-605
R6H1
4B12
CW-1.2
RM4-5
53-7.3
53-6.7
M1/69
PC61.5
1M7
A20
104
MEL-14
H1.2F3
R17217
eBioTY/11.8
RL388
2E7
A7R34
FJK-16s
C-20
D16D10
FJK-16s
11B11
17B7
9D3.1C8
SolA15
B2D

Manufacturer
BD Biosciences
eBioscience
BD Biosciences
eBioscience
eBioscience
eBioscience
eBioscience or Tonbo Biosciences
eBioscience
eBioscience or Tonbo Biosciences
eBioscience
eBioscience
eBioscience or Tonbo Biosciences
eBioscience
eBioscience
eBioscience
eBioscience
eBioscience
eBioscience
eBioscience
eBioscience
eBioscience
eBioscience
Santa Cruz Biotechnology
Cell Signaling Technology
eBioscience
eBioscience
eBioscience
Biolegend
eBioscience
eBioscience

9464

Cell Signaling Technology

4/p-STAT3
D57.2.2E
236B4
A2B1
713412
4B10
H57-597
eBioGL3

BD Biosciences
Cell Signaling Technology
Cell Signaling Technology
BD Biosciences
R&D Systems
BD Biosciences
eBioscience or Tonbo Biosciences
eBioscience
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then stained with intracellular markers for 20 min at RT.
Intracellular Cytokine Staining/ICS Stimulation. T cell were stimulated for 4 h
with 50 ng/ml phorbol 12-myristate 13-acetate (PMA) plus 1 μg/ml ionomycin in the
presence of 1× monensin (GolgiSTOP, BD Bioscience) in 24- or 48-well plates,
depending on cell numbers, at 37°C + 5% CO2 (referred to as ICS stimulation). Cells
were harvested, stained, and processed for flow cytometric analysis as described above.
Phospho-Antibody Staining. Cells were incubated in pre-warmed 1× Phosflow
lyse/fix buffer (BD Biosciences) at 37°C for 10 min. Cells were then pelleted by
centrifugation and washed twice with FACS buffer. After washing, the cells were
permeabilized by adding 1 mL of ice-cold Phosflow Perm Buffer III (BD Biosciences),
and incubated on ice for 30 min. The cells were washed twice with FACS buffer, stained
with phospho-antibodies listed on Table 2-3 for 1 h at RT, and then processed for flow
cytometric analysis.
BrdU Incorporation Assay
Mice were injected intraperitoneally (i.p.) with 1 mg of 5-Bromo-2'-deoxyuridine
(BrdU) stock 3 or 16 h before analysis and analyzed according to manufacturer’s
instructions (BD Biosciences). In short, cells were stained with antibodies specific for
cell-surface markers for 30 min at RT, washed and resuspended in Cytofix/Cytoperm
buffer for 15 min on ice. Cells were then washed with Perm/Wash buffer, incubated in
Cytoperm Plus buffer for 10 min on ice, washed again with Perm/Wash buffer, and
resuspended in Cytofix/Cytoperm buffer. After 5 min incubation on ice, cells were
washed with Perm/Wash buffer, resuspended in PBS containing 300 μg/ml of DNase I
and incubated for 1 h at 37°C. After washing with Perm/Wash buffer again, cells were
stained with anti-BrdU for 20 min and processed for flow cytometric analysis.
Active Capase-3 Staining
Cells obtained from single cell suspensions were first stained for cell surface
markers as described above and then fixed and stained following manufacturer’s
instructions (BD Biosciences). In short, cells were fixed using BD Cytofix/Cytoperm
buffer on ice for at least 1 h. Cell were then washed using BD Perm/Wash buffer, stained
with active Caspase-3 antibody at RT for 30 min, and then processed for flow cytometric
analysis.
Mitochondrial Staining
For measurement of ROS, mitochondrial mass, or mitochondrial potential, cells
were incubated in full Click’s medium containing 10 μM CM-H2DCFDA (5-(and-6)chloromethyl-2,7-dichlorodihydrofluorescein diacetate acetyl ester; Life Technologies),
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10 nM MitoTracker Deep Red (Life Technologies), or 20 nM TMRM (tetramethyl
rhodamine, methyl ester; ImmunoChemistry Technologies), respectively, for 30 min at
37°C before staining surface markers as described above.
Cell Purification and Cultures
Lineage-negative WT and Cd4crePtenfl/fl DN3 or DN3a cells were sorted on
MoFlow (Beckman-Coulter) or Reflection (i-Cyt) sorters. Cell surface markers used for
the identification and/or sorting of individual cell populations are listed on Table 2-4.
DN3 cells were used for Seahorse assay and in vitro cultures with OP9-DL1 cells in the
presence of IL-7 (0.5 ng/ml) and Flt3L (5 ng/ml) for 3–8 days. For metabolic
perturbation, DN3a cells were co-cultured with OP9-DL1 cells in the presence of DCA
(10 mM), galactose (0.5 mM) and galactose oxidase (GAO, 0.3 U/ml), GSH (5 mM), or
NAC (20 mM) for 3–5 days. For T cell differentiation under a stromal cell-free culture
condition, sorted DN3a cells were culture in DLL4 (2 μg/ml)-coated plates, in the
presence of CXCL12 (100 ng/ml) or IL-7 (1 ng/ml) to promote DE or JG-T cell
development, respectively, with or without the indicated inhibitors for 4 days.
Cell Counting
The automated Nexcelom Bioscience Cellometer Auto T4 and Auto 2000 were
used to count cell numbers. Alternatively, cell suspensions were mixed with trypan blue
and manually counted using a hemocytometer chamber.
Cells per mL = Average count per square × the dilution factor × 104
Quantitative Real Time PCR (qRT-PCR)
RNA was extracted from cells using the RNeasy micro kit (Qiagen). cDNA was
synthesized using SuperScript III reverse transcriptase (Invitrogen). An ABI 7900 Realtime PCR system was used for quantitative PCR, with primer and probe sets from
Applied Biosystems.
Results were analyzed with SDS 2.1 software and in GraphPad Prism. The
cycling threshold value of the endogenous control gene (E-actin) was subtracted from the
cycling threshold value of each target gene to generate the change in cycling threshold
(DeltaCT). The expression of each target gene is presented as the fold change relative to
that of wild-type unstimulated samples using the delta delta CT method (Menon et al.,
2007).
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Table 2-4.
Cell surface markers used for the identification and/or sorting of
populations of interest.
Cell Population
DP, pre-selection
DP, post-selection
DN3
DN3a
DN3b
DN4
DN17
iNKT17
ISP
MAIT17

Cell Surface Markers
TCRE CD69–CD4+CD8+
TCRECD69+CD4+CD8+
CD4–CD8–JGTCR–TCRE–CD25hiCD44–
CD4–CD8–JGTCR–TCRE–CD25hiCD44–CD27–
CD4–CD8–JGTCR–TCRE–CD25hiCD44–CD27+
CD4–CD8–JGTCR–TCRE–CD25–CD44–
CCR6+TCRE+CD127+CD1d:PBS57-tet–
MR1:5-OP-RU-tet–
CCR6+TCRE+CD127+CD1d:PBS57tet+MR1:5-OP-RU-tet–
CD4–CD8+TCRE–
CCR6+TCRE+CD127+CD1d:PBS57-tet–
MR1:5-OP-RU-tet+
–
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Western Blotting
A lysing cocktail containing RIPA Lysis and Extraction Buffer (Thermo Fisher
Scientific) plus cOmplete Mini, EDTA-free protease inhibitor cocktail (Roche) and
PhosSTOP phosphatase inhibitor cocktail (Roche) was used to obtain whole-cell lysates.
Lysates were then resolved on SDS-PAGE gels and transferred into polyvinylidene
difluoride membranes (Bio-Rad). Membranes were then blocked with 5% non-fat milk
(Bio-Rad) in Tris-buffered saline (TBS)-T (1× TBS from Bio-Rad containing 0.1%
Tween-20) for at least 1 h at RT shaking. After blocking, membranes were incubated
overnight at 4°C with indicated antibodies diluted in 5% blocking buffer. Membranes
were then washed three times with 0.1% TBS-T for 5 min at RT shaking, followed by
staining of the appropriate Horseradish peroxidase (HRP)-conjugated secondary antibody
in 5% blocking buffer for at least 40 min at RT shaking. After washing the membranes
three times as described above, the bound antibodies were visualized using SuperSignal
West Dura Extended Duration or SuperSignal West Pico PLUS chemiluminescent
substrate (Thermo Fisher Scientific). The images were obtained using a LI-COR
Biosciences Odyssey FC imaging system. The following primary antibodies were used:
EGR1 (44D5), p-ERK (9101), ID3 (D16D10, all from Cell Signaling Technology), and
β-ACTIN (AC-15 from Sigma). All primary antibodies were used at a 1:1,000 dilution,
with the exception of β-ACTIN that was used at 1:20,000 dilution. Secondary antibodies
were used at a 1:5,000 dilution.
Metabolic Assays
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)
were measured in XF media (non-buffered Dulbecco’s Modified Eagle Medium
(DMEM) containing 5 mM glucose, 2 mM L-glutamine and 1 mM sodium pyruvate),
under basal conditions or in response to 1 μM oligomycin (Oligo), 2 μM fluoro-carbonyl
cyanide phenylhydrazone (FCCP), or 1 μM rotenone (Rot) using the XF-24 Extracellular
Flux Analyzer (Seahorse Bioscience), as previously described (Yang et al., 2017).
Microarray Analysis
DNase-treated RNA samples from sort-purified thymocytes were analyzed with
the Affymetrix Mouse Gene 2.0 ST GeneChip array. Gene set enrichment analysis
(GSEA) within hallmark gene sets (MSigDB) or canonical pathways (MSigDB c2.CP
gene sets for canonical pathways) was performed as described (Subramanian et al.,
2005). Differentially expressed transcripts were identified by ANOVA (Partek Genomics
Suit v6.5) and the Benjamin-Hochberg method was used to estimate the false discovery
rate (FDR) as previously described (Wang et al., 2013a). Lists of differentially expressed
genes by > 0.5 log2 difference were analyzed using Ingenuity Pathway Analysis (IPA,
Qiagen, Inc.) for the identification of canonical pathways and upstream transcriptional
regulators.
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Statistical Analysis of Biological Experiments
P values were calculated by two-tailed Mann-Whitney test, two-tailed unpaired
Student’s t-test, or ANOVA using GraphPad Prism software, unless otherwise noted. P
value of < 0.05 was considered significant. All error bars represent mean and standard
error of the mean (SEM).
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CHAPTER 3. ROLE OF RAPTOR/mTORC1 SIGNALING IN LINEAGE
DECISIONS OF ALPHA BETA AND GAMMA DELTA T CELLS2
T cells develop in the thymus, where BM-derived precursors undergo a series of
well-characterized developmental processes that promote differentiation into the distinct
DE and JG-T cell lineages (Yui and Rothenberg, 2014). The divergence of the two T cell
lineages occurs at the DN3 stage of thymocyte development (Ciofani and ZunigaPflucker, 2010). Recent studies suggest signaling strength downstream of the TCR,
mainly mediated by the ERK/EGR1/ID3 signaling axis, plays a key role in determining
lineage choices of thymic progenitors (Hayes et al., 2005; Lee et al., 2014; Robey, 2005).
However, the mechanisms linking extracellular stimuli to intrinsic TCR signaling
strength remain elusive.
The kinase mTOR integrates immune signals and metabolic cues to orchestrate
the function and fate of T lymphocytes (Chi, 2012). Recent studies have highlighted the
involvement of mTOR signaling in thymocyte development (Lee et al., 2012; Tang et al.,
2012), but whether mTOR signaling facilitates DE and JG-T cell lineage choices remains
unknown. Using genetic mouse models, here we explore the role of RAPTOR-dependent
mTORC1 signaling in T cell lineage choices.
Cell Metabolism and mTORC1 Activity Regulation in Thymocyte Development
To understand the metabolic requirements and regulation of developing
thymocytes, oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)
of thymic subsets were measured. OCR and ECAR act as surrogates for the measurement
of cellular oxidative phosphorylation (OXPHOS) and glycolysis, respectively. In
particular, thymic subsets in the late double-negative stages (DN3–DN4 stages), along
with immature single-positive (ISP) and double-positive (DP) thymocytes, were
evaluated at baseline and upon treatment with mitochondrial inhibitors (Figure 3-1).
DN3 and ISP cells, which represent the first thymic stage with full T cell commitment
(Carpenter and Bosselut, 2010) and the intermediate transitional stage between the DN
and DP stages, respectively, showed the highest OCR at basal level (Figure 3-1A).
Furthermore, DN3 cells displayed the greatest spare respiratory capacity (SRC) of the
subsets, which is indicative of how effectively the electron transport chain can respond to
energy demands (Figure 3-1B). As indicated by the ECAR, the glycolytic activity of
thymic subsets was progressively upregulated in the transition from DN3 to ISP cells but
reduced in the quiescent DP cells (Figure 3-1C). These data indicate developing
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signal directs the reciprocal lineage decisions of ab and gd T cells. Science Immunology 3. (* Co-first
authors). DOI: https://doi.org/10.1126/sciimmunol.aas9818.
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Figure 3-1. Developing thymocytes regulate cellular metabolism dynamically.
(A) Oxygen consumption rate (OCR) in thymocyte subsets (DN3, double-negative 3
cells; DN4, double-negative 4 cells; ISP, immature single-positive cells; DP, doublepositive cells) at baseline. (B) OCR in thymocyte subsets in response to oligomycin
(Oligo), carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), and rotenone
(Rot). Spare respiratory capacity (SRC) of DN3 cells is indicated. (C) Measurement of
extracellular acidification rate (ECAR) in freshly isolated thymocyte subsets. Data are
means ± SEM. *P < 0.05, **P < 0.001, and ***P < 0.0001. Two-tailed unpaired t-test.
Data are representative of at least ten independent experiments.
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thymocytes undergo dynamic regulation of their metabolic activity.
Nutrient uptake and mTOR activation are closely linked to metabolic activity in T
cells (Chi, 2012). Similar to the ECAR pattern observed, DN4 and ISP cells had the
highest surface expression of CD98 and CD71, the corresponding amino acid and iron
transporters (Figure 3-2A). Accordingly, these same thymic subsets had the highest
phosphorylation of S6, a target of mTORC1 (Figure 3-2B), suggesting mTORC1
involvement in metabolic regulation of developing thymocytes.
Requirement of RAPTOR in Thymocyte Development
Generation of RAPTOR-Deficient Thymocyte Mice
To evaluate the function of mTORC1 signaling in thymocyte development, we
crossed Cd2-Cre transgenic mice (de Boer et al., 2003) with mice carrying loxP-flanked
Rptor alleles (Rptorfl/fl). This genetic mouse strategy allowed us to delete RAPTOR, an
obligatory component of mTORC1, in early DN cells (mice referred to as
Cd2creRptorfl/fl). Western blotting confirmed deletion of RAPTOR in DN3 cells and
subsequent thymocyte subgrous (Figure 3-3A).
Phenotypic Characterization of T Cell Development in Cd2creRptorfl/fl Mice
RAPTOR Deficiency Impairs the DN-to-DP Transition of Developing DE-T
Cells. Our genetic system showed RAPTOR was required for proper T cell development.
RAPTOR deficiency resulted in greatly reduced thymocyte cellularity driven by a nearly
10-fold reduction in DP cells and considerable reduction in CD4SP and CD8SP cells
(Figure 3-3B). Correspondingly, RAPTOR deficiency caused an accumulation of DN
cells, hinting at a potential blockade at the DN-to-DP transition.
The increased frequency and number of DN cells in the Cd2creRptorfl/fl mice
prompted us to do detailed analysis of the thymic subsets making up the DN-to-DP
transition (Figure 1-2). Flow cytometric analysis showed that the increased number of
DN cells in RAPTOR-deficient thymocytes was driven by accumulation of DN3 cells and
DN4 cells (Figure 3-4A). Furthermore, and in support of a role for RAPTOR in the DNto-DP transition, frequency and number of ISP cells, the transitional stage between DN4
and DP cells, was significantly elevated too (Figure 3-4B).
To confirm a cell-intrinsic role for RAPTOR in the DN-to-DP transition of T cell
development, we generated mixed BM chimeras consisting of congenitally marked
CD45.1+ spike cells and CD45.2+ donor cells from either WT or Cd2creRptorfl/fl mice in a
1:1 ratio. T cell development in the spike and WT donor compartments proceeded
normally, whereas the RAPTOR-deficient T cells had increased DN cells and ISP cells
but reduced DP cells, similar to Cd2creRptorfl/fl mice (Figure 3-4C, D).
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Figure 3-2. Nutrient transporters and mTORC1 activity are dynamically
regulated in developing thymocytes.
(A) Relative surface expression of CD98 and CD71, the respective amino acid and iron
transporters, on thymocyte subsets, as measured by mean fluorescence intensity (MFI)
compared to the expression of DN3 cells (i.e. MFI in DN3 cells is normalized to 1). (B)
Relative phosphorylation of S6, a target of mTORC1, in thymocyte subsets as measured
by MFI compared to the expression of DN3 cells.

Figure 3-3. Cd2-Cre–mediated deletion of RAPTOR impairs DE-T cell
development.
(A) Western blotting of RAPTOR in DN3 and DN4 thymocytes of WT and
Cd2creRptorfl/fl mice. (B) Flow cytometric analysis of thymocyte subsets in WT and
Cd2creRptorfl/fl mice along with the cellularity of total thymocytes and of each major
subset. Data are means ± SEM. *P < 0.05, **P < 0.001, and ***P < 0.0001. Two-tailed
unpaired t-test. Data are representative of at least ten independent experiments. Numbers
indicate percentage of cells in gates.
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Figure 3-4. RAPTOR deficiency blocks the DN-to-DP transition of DE-T cell
development.
(A) Flow cytometric analysis of DN1–4 subsets (gated on lineage-negative DN
thymocytes) in WT and Cd2creRptorfl/fl mice with cellularity on the right. (B) Flow
cytometric analysis (upper panels) and frequency and cellularity (lower panels) of ISP
cells in WT and Cd2creRptorfl/fl mice. (C and D) Flow cytometric analysis of thymocyte
subsets (C) or ISP cells (D) in CD45.2+ WT or Cd2creRptorfl/fl donor-derived cells (upper
panels), or in CD45.1+ spike-derived cells (lower panels) of mixed BM chimeras. (E)
Expression of CD4 and CD8 on WT and Cd2creRptorfl/fl DN3 cells co-cultured with OP9DL1 cells for 3 or 8 days. Data are means ± SEM. *P < 0.05 and **P < 0.01. One-way
ANOVA with Tukey’s test (A), two-tailed Mann-Whitney test (B, frequency), or twotailed unpaired t test (B, cellularity). Data are presentative of at least three independent
experiments. Numbers indicate percentage of cells in quadrants or gates.
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To directly assess the DN-to-DP transition, we cocultured DN3 cells with OP9DL1 stromal cells in vitro for 3–8 days. OP9-DL1 stromal cells have the capacity to
induce a normal program of T cell differentiation from stem cells, including the
generation of DP cells and CD8SP cells, and represent a well-established and simple in
vitro system for the study of T cell development (Ciofani et al., 2006; Zuniga-Pflucker,
2004). In this context, Cd2creRptorfl/fl DN3 cells also showed an impaired capacity to
progress to the DP stage (Figure 3-4E). Collectively, our results suggest RAPTOR
mediates the DN-to-DP transition of developing thymocytes in a cell-autonomous
manner.
To investigate the mechanistic basis for the defective DN-to-DP transition in
Cd2creRptorfl/fl mice, we examined underlying cellular processes, such as cell death and
proliferation. As measured by active caspase-3 staining, no differences in cell apoptosis
were observed in any of the RAPTOR-deficient thymocyte subsets (Figure 3-5A). Cell
proliferation, as measured by in vivo BrdU incorporation, was defective in RAPTORdeficient ISP cells, but not in DN3 cells or DN4 cells (Figure 3-5B). It is important to
note that the proliferative expansion of DN4 cells and ISP cells is known to be preceded
by a period of quiescence at the DN3 stage (Carpenter and Bosselut, 2010).
Notwithstanding, we found induction of intracellular TCRE (icTCRE) occurred largely
normal in the DN populations, including in the TCRE-rearranged DN3b cells that are
beginning the transition to becoming DP cells (Figure 3-5C). Our data, therefore, shows
RAPTOR deficiency does not affect thymocyte survival or pre-TCR induction, but rather
causes defective proliferation and differentiation of DN cells to DP cells.
Loss of RAPTOR Promotes the Development of JG-T Cells. In addition to DET cells, thymocyte progenitors also give rise to JG-T cells, a fundamentally distinct
lineage of T cells (Carpenter and Bosselut, 2010; Ciofani and Zuniga-Pflucker, 2010).
Interestingly, Cd2creRptorfl/fl mice presented a significant enrichment of the JG-T cell
compartment (Figure 3-6A), which resulted in a profound change in the JG to DE-T cell
thymic ratio (Figure 3-6B). This alteration in JG-T cell development was phenocopied by
the mixed BM chimeras previously described (Figure 3-6C) and further confirmed using
the OP9-DL1 in vitro coculture system, in which we cocultured DN3 cells with CD45.1+
spike cells in a 1:1 ratio in the presence of OP9-DL1 stromal cells (Figure 3-6D). These
experimental systems confirmed that this phenomenon was a cell-intrinsic effect of
RAPTOR deficiency in developing T cells and not a secondary consequence of the loss
of DP thymocytes; this is because the CD45.1+ spike cells in both systems undergo
normal development, hence providing a normal thymic microenvironment in terms of
overall cellularity and presence of DP cells.
An interesting observation in terms of JG-T cell development was the upregulation
of CD73 expression (Figures 3-6E through G), an established marker of JG-T cell fate
commitment. Cd2creRptorfl/fl mice had strong enrichment of the CD73+JGTCR+ thymic
population (Figure 3-6E, F), which was reflected in an increased overall mean
fluorescence intensity (MFI) of CD73 expression in the JG-T cell thymic compartment
(Figure 3-6G). These data further support a role for RAPTOR in limiting JG-T cell
development.
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Figure 3-5. Analysis of cell death, proliferation, and intracellular TCRE
E (icTCRE)
induction in thymic subsets of WT and Cd2creRptorfl/fl mice.
(A) Active caspase-3 staining in thymocyte subsets of WT and Cd2creRptorfl/fl mice. (B)
In vivo BrdU incorporation in thymocyte subsets of WT and Cd2creRptorfl/fl mice pulsed
with BrdU 3 h before analysis. (C) icTCRE staining in thymocyte subsets of WT and
Cd2creRptorfl/fl mice. Numbers indicate percentage of cells in gates.
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Figure 3-6. Loss of RAPTOR promotes JG-T cell development.
(A) Flow cytometric analysis (left) and cellularity (right) of TCRJG+ cells in WT and
Cd2creRptorfl/fl thymocytes. (B) Ratio of TCRJG+ to TCRE+ cells in WT and
Cd2creRptorfl/fl thymocytes. (C) Flow cytometric analysis of the TCRJG+ compartment in
CD45.2+ WT or Cd2creRptorfl/fl donor-derived cells (upper panels), or in CD45.1+ spikederived cells (lower panels) of mixed BM chimeras. (D) Expression of CD4 and TCRJG
on WT and Cd2creRptorfl/fl DN3 cells (CD45.2+, upper panels) co-cultured with spike
cells (CD45.1+, bottom panels) in a 1:1 ratio along with OP9-DL1 cells for 4–5 days. (E)
Expression of CD73 and CD24 on CD4–CD8–TCRJG+ cells in the thymus of WT and
Cd2creRptorfl/fl mice. (F) Cellularity of CD73+TCRJG+ cells in E. (G) Expression of CD73
on TCRJG+ cells in the thymus of WT and Cd2creRptorfl/fl mice, with MFI indicated above
graphs. Data are means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001. Two-tailed
unpaired t test (A and F) or one-tailed unpaired t test (B). Data are representative of at
least three independent experiments. Numbers indicate percentage of cells in gates or
quadrants.
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As assessed by Ki67 and active caspase-3 staining respectively, RAPTOR
deficiency did not affect proliferation (Figure 3-7A) or apoptosis (Figure 3-7B) of
TCRJG thymocytes. Collectively, our data suggest RAPTOR acts as a cell-intrinsic
molecular modulator of JG-T cell development.
RICTOR Is Dispensable for JG-T Cell Development
RICTOR is the obligate component of mTORC2. Previous studies have already
reported a role for RICTOR in DE-T cell development (Lee et al., 2012; Tang et al.,
2012), but whether RICTOR was important for JG-T cell development remained unclear.
Using the same crossing strategy as for the Cd2creRptorfl/fl mice, we crossed Cd2-Cre
transgenic mice with mice carrying loxP-flanked Rictor alleles (Rictorfl/fl) to evaluate the
function of RICTOR/mTORC2 signaling in JG-T cell development. Interestingly, our
studies showed RICTOR was dispensable for the development of JG-T cells, as ablation
of RICTOR did not affect the frequency or cellularity of this thymocyte population
(Figure 3-8A), or CD73 expression on TCRJG+ thymocytes (Figure 3-8B). Combined
deletion of RAPTOR and RICTOR further reduced cellularity of total thymocytes,
including JG-T cells, and it had no rescue effects in terms of CD73 expression by TCRJG+
thymocytes (Figure 3-8A, B). These results demonstrate RAPTOR and RICTOR have
discrete roles in JG-T cell development.
RAPTOR Modulates ROS Production in Fate Decisions of DN3 Cells
The dynamic regulation of metabolic activity seen in developing thymocytes
(Figure 3-1), paralleled by mTORC1 activity changes (Figure 3-2), suggested RAPTOR
shaped T cell fate decisions by controlling metabolic reprograming of DN3 cells. To test
this hypothesis, we performed detailed metabolic characterization of RAPTOR-deficient
DN3 cells. Compared to WT, RAPTOR-deficient DN3 cells had intact basal OCR and
slightly reduced SRC (Figure 3-9A). Nonetheless, they showed reduced ECAR (Figure
3-9B), which translated to an altered OCR to ECAR ratio (Figure 3-9C), suggesting
disrupted control of bioenergetics and an increase reliance on oxidative metabolism.
Consequently, RAPTOR-deficient DN3 cells, but no other developing subgroup, had
significantly increased levels of ROS (Figures 3-9D, E). Interestingly, RAPTORdeficient JG-T cells also had elevated ROS production, as compared to their WT
counterparts (Figure 3-9F). Other mitochondrial parameters, such as mitochondrial mass
and mitochondrial membrane potential, as measured by MitoTracker and TMRM staining
respectively, were comparable between WT and RAPTOR-deficient DN3 cells (Figures
3-9G, H). These results suggest RAPTOR deficiency impairs metabolic remodeling and
promotes ROS production in DN3 cells.
To study the potential link between changes in ROS production and metabolic
activities of DN3 cells with subsequent fate decisions, we performed in vitro assays to
directly assess these phenomena. First, we co-cultured DN3a cells with OP9-DL1 stromal
cells in the presence of two known promoters of ROS production: galactose (Gal) and
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Figure 3-7. Analysis of proliferation and apoptosis in RAPTOR-deficient JG-T
cells.
(A) Ki67 staining in TCRJG+ cells in WT and Cd2creRptorfl/fl thymocytes. (B) Active
caspase-3 staining in TCRJG+ cells in WT and Cd2creRptorfl/fl thymocytes. Numbers
indicate percentage of cells in gates.
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Figure 3-8. Loss of RICTOR does not affect the development of JG-T cells.
(A) Flow cytometric analysis of TCRJG+ thymocytes in WT, Cd2creRptorfl/fl,
Cd2creRictorfl/fl, and Cd2creRptorfl/flRictorfl/fl mice (upper panels), along with frequencies
and cellularity (bottom panels). (B) Flow cytometric analysis of CD73 and CD24
expression by TCRJG+ thymocytes in WT, Cd2creRptorfl/fl, Cd2creRictorfl/fl, and
Cd2creRptorfl/flRictorfl/fl mice. Data are means ± SEM. **P < 0.01 and ***P < 0.001.
One-way ANOVA with Tukey’s test. Data are presentative of at least three independent
experiments. Numbers indicate percentage of cells in gates or quadrants.
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Figure 3-9. RAPTOR modules ROS production DN3 and JG-T cells.
(A) OCR in WT and Cd2creRptorfl/fl DN3 cells under basal conditions or in response to
the indicated mitochondrial inhibitors. SRC of WT and Cd2creRptorfl/fl DN3 cells is
indicated. (B) Measurement of ECAR in WT and Cd2creRptorfl/fl DN3 cells. (C) Ratio of
OCR to ECAR in WT and Cd2creRptorfl/fl DN3 cells. (D) Analysis of ROS production in
WT and Cd2creRptorfl/fl DN3 cells. (E) Relative MFI of ROS in thymocyte subsets of WT
and Cd2creRptorfl/fl mice (MFI of WT DN3 cells is normalized to 1). (F) Analysis of ROS
production in WT and Cd2creRptorfl/fl JG-T cells. (G and H) Plots of MitoTracker (G) and
TMRM (H) in WT and Cd2creRptorfl/fl DN3 cells. Data are means ± SEM. ***P < 0.001.
Two-way ANOVA with Bonferroni’s test. Data are the combination of three independent
experiments (A to C) or representative/combination of two independent experiments (D
to H).
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galactose oxidase (GAO) (Sena et al., 2013). Gal/GAO treatment caused enrichment of
the JG-T cell compartment and loss of the DE-T cell lineage (Figure 3-10A). Second, we
treated DN3a cells in the presence of OP9-DL1 stromal cells with dichloroacetate (DCA),
an inhibitor of the mitochondrial enzyme pyruvate dehydrogenase kinase (PDK).
Inhibition of PDK activates pyruvate dehydrogenase (PDH), which shifts glycolysis into
fueling OXPHOS in the mitochondria (Gerriets et al., 2015). Similar to Gal/Gao
treatment, though not to the same extend, DCA treatment promoted JG-T cell
development at the expense of DE-T cells (Figure 3-10B). The effects of DCA on DN3a
cells were associated with increased ROS production (Figure 3-10C). To exclude
potential effects of the pharmacological agents on the OP9-DL1 cells, we performed
similar experiments in the context of a stromal cell-free system for in vitro differentiation
of thymocytes (Tussiwand et al., 2011). The results were consistent with those of the
OP9-DL1 coculture system (Figure 3-10D). The used of the stromal cell-free system
confirmed that the pharmacological effects were mediated by changes in ROS signaling
in the DN3a cells and not in the stromal cells. Finally, treatment of WT DN3a cells with
the ROS scavengers N-acetyl-L-cysteine (NAC) or glutathione (GSH) diminished JG-T
cell development (Figure 3-10E) and promoted the generation of DE-T cells (Figure
3-10F), further supporting a role for ROS signaling in DN3 cell fate choices.
Considering the aforementioned evidence supporting a role for ROS in DN3 cell
lineage choices, we next tested whether ROS neutralization could rescue the altered fate
choices of RAPTOR-deficient DN3 cells. To this end, we cocultured RAPTOR-deficient
DN3 cells with OP9-DL1 cells in the presence of NAC and followed their fate decisions
via flow cytometric analysis. NAC treatment significantly, though not completely,
suppressed the generation of JG-T cells derived from RAPTOR-deficient DN3a cells and
restored their defective DE-T cell generation (Figure 3-11A). The effects of NAC
treatment on RAPTOR-deficient DN3a cells largely rescued the altered JG to DE-T cell
ratio observed in these cells (Figure 3-11A). Furthermore, NAC treatment restored the
impaired transition of RAPTOR-deficient DN3 cells to the DN4 stage (Figure 3-11B).
Noticeably, NAC treatment did not improve the cellularity of RAPTOR-deficient DN3
cells (Figure 3-11C), suggesting that ROS regulation of DN3 lineage choices was
independent of cell expansion. Altogether, these results indicate RAPTOR-dependent
metabolic remodeling tunes ROS production in DN3 cells, which acts as a metabolic
signal in dictating lineage choices.
RAPTOR Tunes the Strength of the ERK/EGR1/ID3 Signaling Axis
It is well appreciated that TCR signaling strength influences lineage decisions of
developing thymocytes (Carpenter and Bosselut, 2010; Ciofani and Zuniga-Pflucker,
2010). Strong TCR signaling mediated by the ERK/EGR1/ID3 signaling axis favors the
development of JG-T cells (Haks et al., 2005; Hayes et al., 2005). Thus, we investigated
whether RAPTOR controlled the ERK/EGR1/ID3 signaling axis of DN3 cells. As
compared to their WT counterparts, RAPTOR-deficient DN3 cells had elevated
phosphorylation of ERK, along with increased expression of EGR1 and ID3 (Figures
3-12A through C). We then crossed mice with the Erk2 gene flanked by loxP sites with
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Figure 3-10. Modulation of ROS production alters fate choices of DN3 cells.
(A) Analysis of CD4 and TCRJG expression in WT DN3 cells cocultured with OP9-DL1
cells in the absence or presence of Gal/GAO for 5 days (left), along with frequencies and
cellularity (right). (B) Analysis of CD4 and TCRJG expression in WT DN3 cells
cocultured with OP9-DL1 cells in the absence or presence of DCA for 5 days (top), along
with bar graph depicting fold change of the ratio of TCRJG+ to CD4+ cells upon DCA
treatment (bottom). (C) Analysis of ROS production in WT DN3a cells cocultured with
OP9-DL1 cells in the absence or presence of DCA for 3 days, with MFI plotted in graphs.
(D) Analysis of CD4 and TCRJG expression in WT DN3 cells cultured on plate-bound
NOTCH ligand DLL4 in the presence of CXCL12 and treated with the indicated
inhibitors (left), along with frequencies of TCRJG+ cells in each condition (right). (E and
F) Analysis of CD4 and TCRJG expression (E) and CD4 and CD8 expression (F) in WT
DN3 cells cocultured with OP9-DL1 cells in the absence or presence of NAC or GSH for
3 days (left), along with number of TCRJG+ cells (E) or DP cells (F) in each condition
(right). Data are means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001. Two-tailed
Mann-Whitney test (A for frequency analysis), two-tailed unpaired t test (A for
cellularity analysis), one-tailed unpaired t test (B), or one-way ANOVA with Tukey’s test
(E, F). Data are representative of at least three independent experiments. Numbers
indicate percentage of cells in gates or quadrants.
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Figure 3-11. RAPTOR-dependent control of ROS production impacts fate choices
of DN3 cells.
(A and B) Analysis of CD4 and TCRJG expression (A) and CD25 and CD44 expression
(B) in WT and Cd2creRptorfl/fl DN3 cells cocultured with OP9-DL1 cells in the absence or
presence of NAC for 5 days, along with fold changes of the ratios of TCRJG+ cells to
CD4+ cells (A, center) and CD25+ cells to CD25+ cells (B, right), and frequencies of
TCRJG+ cells and CD4+ cells (A, right). (C) Cellularity of total cells in (B). Data are
means ± SEM. *P < 0.05, and ***P < 0.001. One-way ANOVA with Tukey’s test (A, B),
or two-tailed unpaired t test (C). Data are representative of at least three independent
experiments. Numbers indicate percentage of cells in gates or quadrants.
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Figure 3-12. RAPTOR tunes the strength of the ERK/EGR1/ID3 signaling axis in
DN3 cells.
(A) Immunoblot analysis of p-ERK, EGR1, ID3, and E-ACTIN in WT and Cd2creRptorfl/fl
DN3 cells. (B and C) Flow cytometric analysis of p-ERK (B) and ID3 expression (C) in
WT and Cd2creRptorfl/fl DN3 cells, with MFI plotted in graphs. (D) Cellularity of
CD4+CD8+ DP cells from the indicated mice. Each symbol represents an individual
mouse. (E) Flow cytometric analysis of CD73 and CD24 expression on TCRJG+
thymocytes in the indicated mice (left), along with frequency and cellularity of
CD73+TCRJG+ cells. (F) Expression of CD73 on TCRJG+ thymocytes in (E) shown as
fold change (MFI on WT cells is normalized to 1). Data are means ± SEM. *P < 0.05,
and ***P < 0.001. One-way ANOVA with Tukey’s test. Data are representative of at
least three independent experiments. Numbers indicate percentage of cells in quadrants.
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Cd2creRptorfl/fl mice to delete ERK2 in the RAPTOR-deficient background. The resulting
mice (Cd2creRptorfl/flErk2fl/fl) did not show improved cellularity of DP thymocytes as
compared to Cd2creRptorfl/fl mice (Figure 3-12D). However, they rescued the
accumulation of CD73+ JG-T cells (Figure 3-12E) and the elevated surface expression of
CD73 in JG-T cells observed in Cd2creRptorfl/fl mice (Figure 3-12F). These results
suggest deletion of RAPTOR in DN3 cells leads to elevated signaling strength of the
ERK/EGR1/ID3 signaling pathway, which in turn favors development of JG-T cells.
To assess whether changes in ROS levels were related to changes in signaling
strength, we measured ID3 expression via flow cytometry in DCA-treated WT DN3a
cells cocultured with OP9-DL1 cells. DCA, which promoted ROS production in DN3a
cells (Figure 3-10C) and enhanced JG-T cell development at the expense of DE-T cells
(Figure 3-10B, D), increased the expression of ID3 in WT DN3a cells after 3 days of
treatment in the presence of OP9-DL1 cells (Figure 3-13A). This effect was
accompanied by a marked increase in CD73 expression on TCRJG+ cells from the
cocultures of WT DN3a cells with OP9-DL1 cells (Figure 3-13B). Gal/GAO treatment
of WT DN3a cells cocultured with OP9-DL1 cells, which had striking effects on the
promotion of JG-T cell development and inhibition of the DE-T cell lineage (Figure
3-10A), also caused increased CD73 expression on TCRJG+ cells from the cocultures of
WT DN3a cells with OP9-DL1 cells (Figure 3-13C). Altogether, these results indicate
mTORC1 activity and ROS metabolism influence TCR signaling strength and,
consequently, linage choices of DN3 cells, by impinging on the activity of the
ERK/EGR1/ID3 signaling axis.
Summary
In this chapter, we evaluated the metabolic activity of developing thymocytes and
uncovered a dynamic regulation of cell metabolism associated with mTORC1 activity.
Using a genetic mouse system to delete Rptor, the obligate component of mTORC1,
specifically in developing thymocytes, we explored the role of RAPTOR/mTORC1
signaling in T cell development. We discovered RAPTOR deficiency impairs the DN-toDP transition of developing thymocytes in the DE-T cell lineage while enhancing the
development of their TCRJG+ counterparts. This observation was confirmed in the
context of mixed BM chimeras, which circumvented the potential secondary
consequences of reduced DP cellularity in Cd2creRptorfl/fl mice, as well as in in vitro
coculture experiments with OP9-DL1 stromal cells. Though it was known that RICTOR,
the obligate component of mTORC2, was essential for the development of DE-T cells
(Lee et al., 2012; Tang et al., 2012), whether mTORC2 signaling was required for JG-T
cell development remained unknown. To this end, we deleted Rictor in early DN cells
using Cd2-Cre-mediated deletion and found RICTOR was dispensable for the
development of JG-T cells. These results highlighted a unique role for RAPTOR in the
lineage choices of DN3 cells. We then explored the effects of RAPTOR deficiency in the
metabolic fitness of DN3 cells and observed disrupted control of bioenergetics and an
increase reliance on oxidative metabolism, associated with elevated ROS production. In
vitro modulation of ROS production in DN3 cells confirmed a role for RAPTOR in
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Figure 3-13. Elevated ROS production increases expression of ID3 in DN3 cells
and CD73 on JG-T cells.
(A) Analysis of ID3 expression in WT DN3a cells after 3 days cocultured with OP9-DL1
cells in the absence or presence of DCA. (B and C) Analysis of CD73 expression on
TCRJG+ cells from coculture of WT DN3a cells with OP9-DL1 cells for 3 days in the
absence or presence of DCA (B) or Gal/GAO (C). Data are representative of at least three
independent experiments. Numbers indicate MFI.
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controlling ROS levels, which ultimately affected fate choices of DN3 cells. Finally, we
explored the relationship between RAPTOR and the ERK/EGR1/ID3 signaling axis,
given that TCR signaling strength is known to govern fate choices of developing
thymocytes (Carpenter and Bosselut, 2010; Ciofani and Zuniga-Pflucker, 2010) and, in
particular, strong signaling strength favors JG-T cells (Haks et al., 2005; Hayes et al.,
2005). Our studies indicated that mTORC1 activity and ROS metabolism tuned the
activity of the ERK/EGR1/ID3 signaling axis, which controls TCR signaling strength,
and, therefore, influenced lineage choices of DN3 cells. Altogether, the studies in this
chapter establish mTORC1 signaling as a key mediator of T cell lineage choices and
reveal ROS as an important metabolic signal in this process.
OT DELETE THE NEXT PAGE BREAK, as it triggers the Chapter 4 title coding at
the top of the next page.
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CHAPTER 4.

PTEN-MEDIATED CONTROL OF UNCONVENTIONAL IL-17PRODUCING THYMOCYTE DEVELOPMENT

In Chapter 3, we uncovered the fate-sorting role of RAPTOR/mTORC1
signaling in T cell development. In this chapter, we focused our efforts on unraveling the
role of PTEN, an upstream regulator of mTOR signaling, in the development of
unconventional TCRDE+ T cells. PTEN is a lipid phosphatase that hydrolyses PIP3,
thereby inhibiting the PI3K-mediated phosphorylation of PIP2. Thus, PTEN inhibits both
mTORC1 and mTORC2 signaling (Chi, 2012). Additionally, PTEN possesses protein
phosphatase activity and phosphatase-independent functions (Shi et al., 2012). In this
way, PTEN controls a number of events that are central to T cell biology, including
proliferation, survival, differentiation, energy metabolism, and cellular architecture and
mobility (Chen and Guo, 2017). In fact, deletion of Pten in T cells results in autoimmune
disorders and lymphoma (Buckler et al., 2008). Although the role of PTEN in T cell
development has been studied, current knowledge of the functions of PTEN in innate-like
unconventional T cells is limited.
Innate-like unconventional T cells share features of adaptive and innate immune
cells. They have an activated phenotype, which grants them with the ability to mount
relatively immediate immune responses in response to non-cognate antigen stimulation
(Godfrey et al., 2015). These unique subsets of T cells are of critical interest as they have
been shown to play important roles in tissue homeostasis and diseases (Iwabuchi and Van
Kaer, 2019). However, the precise molecular mechanisms underpinning their
development remain elusive. In this chapter, we explore the role of PTEN in the
development of unconventional IL-17-producing TCRDE+ thymocytes.
T Cell-Specific Deletion of Pten Promotes the Development of Unconventional IL17-Producing Thymocytes
Generation of Mice with T Cell-Specific Deletion of Pten
To explore the roles of PTEN in the development of unconventional TCRDE+
thymocytes, we crossed Cd4-Cre transgenic mice with mice carrying loxP-flanked Pten
alleles (Ptenfl/fl). This genetic mouse model allowed us to delete Pten specifically in Tlineage cells (mice referred to as Cd4crePtenfl/fl). Because TCRDE+ lymphocytes go
through a CD4+CD8+ DP stage during development (Figure 1-2), PTEN is deleted in all
thymocytes derived from this DP population in the Cd4crePtenfl/fl mice. Previous studies
have confirmed deletion of PTEN in the DP population of Cd4crePtenfl/fl mice and
reported the development of fatal T cell lymphomas in these mice by 10-16 weeks of age
(Hagenbeek and Spits, 2008). The tumorigenic effect of PTEN deletion in the T cell
compartment, along with the development of autoimmune disorders, is a well-established
and extensively studied phenotype (Finlay et al., 2009; Suzuki et al., 2001; Xue et al.,
2008). To study the role of PTEN in the normal development of TCRDE+ thymocytes,
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and to avoid the defects associated with tumorigenesis, we analyzed young (4–6 weeks of
age) Cd4crePtenfl/fl mice before they developed thymoma. The frequency and cellularity
of the thymic subsets in young Cd4crePtenfl/fl mice were comparable with WT mice,
suggesting T cell development is relatively normal in these mice at this age (Figure
4-1A).
To determine whether PTEN deletion had effects on the development of effector
T cells in the thymus, we analyzed cytokine production in young Cd4crePtenfl/fl mice.
Interestingly, we found strong enrichment of IL-17A and IL-17F production (Figure
4-1B). This effect was specific to the IL-17 family of cytokines as no other cytokine was
enriched in the thymus of Cd4crePtenfl/fl mice (Figure 4-1B). These results suggest that
PTEN negatively regulates the development of IL-17-producing thymocytes.
Phenotypic Characterization of IL-17-Producing Thymocytes in Cd4crePtenfl/fl Mice
The enrichment of IL-17 production in the thymus of Cd4crePtenfl/fl mice was
striking, as this cytokine is produced at low levels by WT thymocytes under homeostasis
(Figure 4-1B). RORJt+ is the master transcription factor that promotes IL-17 gene
expression. As expected, the IL-17-producing thymocytes in Cd4crePtenfl/fl mice were
RORJt+ and had intermediate expression of TCRE (TCREint) on the cell surface (Figure
4-2A). Additionally, they expressed other receptors associated with type 17 lymphocytes:
chemokine receptor 6 (CCR6) and IL-7 receptor (CD127) (Figure 4-2A). Since the IL17-producing population co-expressed CCR6 and CD127, we used these surface markers
as surrogates to identify the aberrant IL-17-producing population (Figure 4-2B). We next
assessed the expression of CD4 and CD8 coreceptors. Interestingly, the vast majority of
IL-17-producing thymocytes in Cd4crePtenfl/fl mice were not CD4+ T cells (nTH17), but
instead were a heterogeneous population of CD8+ SP, CD4–CD8– DN, and CD4+CD8+
DP cells (Figure 4-2C). This suggests that the IL-17-producing thymocytes in
Cd4crePtenfl/fl mice are not classical nTH17 cells, but rather a population of
unconventional T cells.
IL-17-Producing Lymphocytes in Cd4crePtenfl/fl Mice Reside in the Thymus
The enrichment of IL-17-producing lymphocytes in Cd4crePtenfl/fl mice was
restricted to the thymus, as no aberrant IL-17 production was observed in peripheral
organs (Figure 4-3A). This observation prompted us to assess the surface expression of
L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 (S1PR1), molecules required
for thymocyte egress from the thymus into peripheral tissues (Arbones et al., 1994;
Matloubian et al., 2004). As compared to mature CD8SP cells and DP cells, the
CCR6+CD127+ population in Cd4crePtenfl/fl mice had markedly reduced expression of
CD62L and S1PR1 expression, respectively (Figure 4-3B). Developing thymocytes must
downregulate CD69 to allow for S1PR1 expression on the cell surface (Kimura et al.,
2018; Matloubian et al., 2004). As compared to DP cells, which had the highest S1PR1
expression, the CCR6+CD127+ population in Cd4crePtenfl/fl mice had elevated surface
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Figure 4-1. Cd4-Cre–mediated deletion of Pten induces the enrichment of IL-17
production in thymus.
(A) Flow cytometric analysis of thymocyte subsets in WT and Cd4crePtenfl/fl mice, along
with frequencies (center) and cellularity (right) of each major thymocyte subset. (B)
Analysis of cytokine production in thymus of WT and Cd4crePtenfl/fl mice after ICS
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expression of CD69, though not to the same extend as mature CD8SP (Figure 4-3B).
Finally, we evaluated the expression of CD103, a mucosal homing receptor associated
with tissue residency (Rahimpour et al., 2015). We found that the CCR6+CD127+
population in Cd4crePtenfl/fl mice had high CD103 expression (Figure 4-3B). These
results suggest that PTEN-deficient IL-17-producing thymocytes reside in the thymus.
To confirm that the PTEN-deficient IL-17-producing lymphocytes resided in
thymus, and not that they were losing IL-17 expression in periphery, we used a fatemapping system to permanently mark with green fluorescent protein (GFP) cells that
express IL-17. We crossed Il17-iCre mice with ROSA26GFP reporter mice on the Pten+/–
(germline deletion of one allele) background (mice referred to as Pten+/–
Il17icreRosa26GFP). Although Pten+/– mice had a much weaker IL-17 phenotype than
Cd4crePtenfl/fl mice (data not shown), Pten+/–Il17icreRosa26GFP mice still had slight
enrichment of IL-17-producing thymocytes (Figure 4-3C). No major differences in
frequency of peripheral GFP-tagged cells were observed between WT and Pten+/–
Il17icreRosa26GFP mice (Figure 4-3D). These results further support that the aberrant IL17-producing thymocyte population that emerges in the absence of PTEN is thymicresident.
Composition of Unconventional IL-17-Producing Thymocyte Population in
Cd4crePtenfl/fl Mice
iNKT17 and Tc17 Cells
Our lab previously demonstrated that PTEN deficiency enhances the
differentiation of iNKT17 cells in thymus (Wei et al., 2014). Nevertheless, iNKT17 cells
did not account for the totality of the IL-17-producing thymocytes observed in
Cd4crePtenfl/fl mice (Figure 4-4A). Based on TCRE (Figures 4-2A and 4-4B) and CD3
(Figure 4-4B) surface expression, it was clear that the PTEN-deficient IL-17-producing
thymocytes belonged to the TCRDE-lineage of T cells and were not type 3 innate
lymphoid cells (ILC3, TCRE–) or lymphoid tissue inducers (LTi, CD3–). The absence of
the CD4 coreceptor and concomitant enrichment of the CD8 coreceptor among a large
portion of IL-17-producing thymocytes in Cd4crePtenfl/fl mice (Figure 4-2B) suggested
that IL-17-secreting CD8 T cells (Tc17) may be enriched in this cell population.
Downregulation of the T-box factors, T-box transcription factor (T-BET) and
eomesodermin (EOMES), is required for CD8+ T cells to produce IL-17 (Intlekofer et al.,
2005). Neither T-BET nor EOMES protein expression was detected in the IL-17producing thymocyte population of the Cd4crePtenfl/fl mice (Figure 4-4C). These data
suggest that thymic IL-17-producing cells in Cd4crePtenfl/fl mice share similar phenotypic
characterizations as Tc17 cells.
To further characterize the population of PTEN-deficient IL-17-producing
thymocytes, we next used microarrays to compare the transcriptional profiles of the noniNKT17 fraction (CD1d:PBS57-tet–TCREintCCR6+CD127+) against mature CD8SP cells
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(TCRE+CD8+CD4–) in Cd4crePtenfl/fl mice. Using the differentially expressed genes at the
1.5-fold change cut-offs, we performed ingenuity pathway analysis (IPA) to predict
upstream transcriptional regulators. The transcription factor PLZF, encoded by the
Zbtb16 gene, was the top predicted transcriptional regulator (Figure 4-5). PLZF is
specifically expressed in NKT and MAIT cells, but not in conventional T cells or NK
cells, and it directs the acquisition of effector programs by these two unconventional T
cell lineages (Cao et al., 2018; Garner et al., 2018; Kovalovsky et al., 2008; Mao et al.,
2016; Savage et al., 2008). The striking enrichment of PLZF downstream target genes in
the non-iNKT fraction of the PTEN-deficient IL-17-producing thymocytes prompted us
to investigate whether these cells were MAIT cells.
MAIT17 Cells
MAIT cells are easily identifiable by their binding to 5-OP-RU-loaded MR1
tetramers (Rahimpour et al., 2015). Staining of PTEN-deficient thymocytes with the
antigen-loaded MR1 tetramer showed that approximately 40 percent of the IL-17producing cells in Cd4crePtenfl/fl mice were MAIT17 cells (Figure 4-6A). Further, there
was a nearly 20-fold enrichment of MAIT cells in the thymus of Cd4crePtenfl/fl mice
(Figure 4-6B). Interestingly, the enrichment of MAIT cells was specific to the MAIT17
compartment, given that nearly all MAIT cells were IL-17-producing cells (Figure
4-6B). These results highlight a role for PTEN in restricting the development of type 17
unconventional T cells, particularly iNKT17 cells, as previously reported, and MAIT17
cells.
We next evaluated the developmental status of the PTEN-deficient MAIT cells.
Intrathymic MAIT cell development is a three-stage process that can be followed by the
surface expression of CD44 and CD24 (Koay et al., 2016): CD44–CD24+ immature cells
(S1) progress into an intermediate CD44–CD24–stage (S2) to then become CD44+CD24–
mature cells (S3). Remarkably, nearly all PTEN-deficient MAIT cells were mature S3
cells (Figure 4-6C). This observation is in contrast to PTEN-deficient iNKT cells, which
are stalled in their transition from stage 2 to stage 3 (Wei et al., 2014). These results show
that PTEN deficiency leads to the accumulation of mature thymic-resident MAIT17 cells.
Recent studies have highlighted the importance of the inducible T cell
costimulator (ICOS) receptor in the optimal activation of MAIT cells (Koay et al., 2019;
Wang et al., 2019). Signaling through ICOS also promotes the establishment of the
iNKT17 effector lineage (Niu et al., 2018; Wu et al., 2014). We found nearly all PTENdeficient MAIT cells expressed high levels of ICOS (Figure 4-6D). Furthermore, the
total PTEN-deficient TCREintCCR6+CD127+ population, as opposed to just the MAIT or
iNKT fractions, displayed high ICOS expression (Figure 4-6E). These results suggest
that signaling through ICOS may contribute to the establishment of the PTEN-deficient
IL-17-producing thymocyte population.
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Figure 4-5. Ingenuity pathway analysis (IPA) of the differentially expressed genes
EintCCR6+CD127+ cells, as
in the non-iNKT17 fragment of PTEN-deficient TCRE
compared to mature CD8SP cells (TCRE+CD8+CD4–) in Cd4crePtenfl/fl mice.
IPA of transcriptional regulators and ligand-dependent nuclear receptors predicted to be
activated in the non-iNKT17 fragment of PTEN-deficient TCREintCCR6+CD127+ cells,
based on the differentially expressed genes at the 1.5-fold cut-offs as compared to mature
CD8SP cells (TCRE+CD8+CD4-) in Cd4crePtenfl/fl mice.
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Figure 4-6. Characterization of MAIT17 cells in Cd4crePtenfl/fl mice.
(A) 5-OP-RU-loaded MR1 tetramer and PBS57-loaded CD1d tetramer staining of IL-17producing thymocyte population in WT and Cd4crePtenfl/fl mice, along with the average
frequency distribution of each subset (pie chart, bottom left), total frequencies (top right),
and cellularity (bottom right). (B) Analysis of cytokine production by thymic MAIT cells
after ICS stimulation, along with cellularity of MAIT1 cells (IFNJ-producing MAIT
cells, top right) and MAIT17 cells (IL-17A-producing MAIT cells, bottom right). (C)
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DD+ and CD4–CD8– Type 17 (DN17) Cells
CD8D
Although iNKT17 cells and MAIT17 cells were enriched among the PTENdeficient IL-17-producing thymocytes, these two populations did not account for all the
IL-17-producing cells (Figure 4-6A). To characterize the unidentified fraction of cells,
we performed microarray analysis of the three subsets and compared their respective
transcriptional profiles. Principal component analysis (PCA) and differential expression
comparisons of the identified genes showed similar transcriptional profiles between the
iNKT17 and MAIT17 subsets, but a clearly distinct transcriptome for the remaining
CD1d:PBS57-tet–MR1:5-OP-RU-tet– (DN) population (Figure 4-7A, B). The similar
transcriptional profiles shared by iNKT17 cells and MAIT17 cells in Cd4crePtenfl/fl mice
was consistent with a previous study reporting on a common transcriptomic program
acquired in the thymus by these unconventional T cells (Salou et al., 2019). Gene
ontology (GO) analysis of differentially expressed genes at the 1.5-fold change cut-offs
in the IL-17-producing CD1d:PBS57-tet–MR1:5-OP-RU-tet– population showed these
cells were enriched for genes associated with cell activation (Figure 4-7C). IPA analysis
revealed PTEN-deficiency affected multiple canonical pathways implicated in T helper
cell differentiation, activation, autoimmune diseases, immune signaling mediated by
costimulatory molecules, and others (Figure 4-8).
Clearly, the IL-17-producing thymocyte population in Cd4crePtenfl/fl mice was
highly heterogeneous, and the CD1d:PBS57-tet–MR1:5-OP-RU-tet– fraction was
markedly different from the two semi-invariant unconventional T cell populations so far
identified. Next, we reassessed the expression of CD4 and CD8 coreceptors among the
CD1d:PBS57-tet–MR1:5-OP-RU-tet– fraction of the IL-17-producing thymocytes. As
shown in Figure 4-9A, these cells were mainly CD8 single-positive and CD4 CD8
double-negative. Within those expressing the CD8 coreceptor, we evaluated the
differential expression of the CD8 D- and E- chains. Surprisingly, nearly two thirds of the
CD8+ cells expressed the CD8DD homodimer, rather than the typical CD8DE heterodimer
(Figure 4-9A). The CD8DD homodimer does not behave as a coreceptor but instead
binds to the nonclassical MHC molecule thymic leukemia (TL) antigen (Leishman et al.,
2001). This is in contrast to the CD8DE heterodimer, which is a TCR coreceptor that
enhances functional avidity and that is constitutively expressed on MHC class I-restricted
T cells. Therefore, we considered the CD8DE-expressing fraction to be Tc17 cells and
further investigated the CD8DD cells.
CD8DD T cells are generally considered intraepithelial lymphocytes (IEL) that
have self-reactive, but not self-destructive, features, which enable them to act as a
regulatory cell population that maintains tolerance in the gut (Cheroutre, 2004; OlivaresVillagomez and Van Kaer, 2018). Thymic CD8DD T cells are immature IEL precursors
that become CD4, CD8DE, and CD8DD triple-positive (TP) progenitors before
undergoing agonist selection. After selection, they lose expression of all three coreceptors
and leave the thymus and migrate directly to the gut as CD4–CD8– DN TCRDE+
lymphocytes that display the CD5 receptor on their surface (Gangadharan et al., 2006).
Upon entering the IL-15-rich environment of the intestine, CD8DD progenitors become
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Figure 4-7. Microarray analysis of IL-17-producing thymocyte subpopulations in
Cd4crePtenfl/fl mice.
(A) PCA mapping of the iNKT17 (CD1d:PBS57-tet+, labeled as CD1d), MAIT17
(MR1:5-OP-RU-tet+, labeled as MR1), and CD1d:PBS57-tet–MR1:5-OP-RU-tet– (labeled
as DN) fractions of the IL-17-producing thymocyte population in Cd4crePtenfl/fl mice. (B)
Heat map of the transcriptional profiles of the iNKT17 (labeled as CD1d+), MAIT17
(labeled as MR1+), and CD1d:PBS57-tet–MR1:5-OP-RU-tet– (labeled as CD1d–MR1–)
fractions of the IL-17-producing thymocyte population in Cd4crePtenfl/fl mice. (C) List of
top 15 gene sets upregulated in the CD1d:PBS57-tet–MR1:5-OP-RU-tet– fraction of the
IL-17-producing thymocyte population of Cd4crePtenfl/fl mice by gene ontology, based on
the differentially expressed genes at the 1.5-fold cut-offs, as compared to the iNKT17 and
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Figure 4-8. Ingenuity pathway analysis (IPA) of the differentially expressed genes
in the CD1d:PBS57-tet–MR1:5-OP-RU-tet– fraction of the IL-17-producing
thymocyte population of Cd4crePtenfl/fl mice.
IPA of canonical pathways enriched within the differentially expressed genes at the 1.5fold cut-offs of the CD1d:PBS57-tet–MR1:5-OP-RU-tet– fraction of the IL-17-producing
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fractions combined.
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Figure 4-9. Phenotypic characterization of the CD1d:PBS57-tet–MR1:5-OP-RUtet– fraction of CCR6+CD127+ thymocytes.
(A) Flow cytometric analysis of CD4 and CD8D expression on CCR6+CD127+
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mature CD8DD+TCRDE+ IELs (Bruce and Cantorna, 2011). This dynamic expression of
coreceptors appeared to be paralleled by the CD1d:PBS57-tet–MR1:5-OP-RU-tet–
fraction of the IL-17-producing thymocyte population of Cd4crePtenfl/fl mice, which
showed significantly enriched CD8DD+, TP, and CD5-expressing DN sub-fractions
(Figures 4-9A, B).
It was recently reported that CD8DD+ IELs arise from two main thymic precursors
that express either PD-1 (PD-1+T-BET–, type A IELp) or T-BET (PD-1–T-BET+, type B
IELp) (Ruscher et al., 2017). We previously showed that the PTEN-deficient IL-17producing thymocytes were T-BET– (Figure 4-4C), so we next assessed PD-1 expression
within the CD1d:PBS57-tet–MR1:5-OP-RU-tet–CD4–CD8– (referred to as DN17)
fraction. The vast majority of DN17 cells in Cd4crePtenfl/fl mice were PD-1+, consistent
with a type A IELp phenotype (Figure 4-9B). The expression of the cytokine receptor
subunit CD122 (IL-2RE; shared with the receptor for the cytokine IL-15) is characteristic
of IELps and mature TCRDE+ IELs (Olivares-Villagomez and Van Kaer, 2018).
Strikingly, CD122 protein expression was not detected on PTEN-deficient DN17 cells
(Figure 4-9B). However, Sca-1 (Ly-6A), which in peripheral CD4–CD8– DN cells has
been implicated in mediating immunosuppressive functions (Holmes and Stanford, 2007;
Lee et al., 2011; Zhang et al., 2002), was highly expressed (Figure 4-9B), Thus, these
data suggest PTEN-deficient DN17 cells are not bona fide IELps, but rather an
undescribed IL-17-producing DN population that resides in the thymus.
Cell-Intrinsic Role of PTEN in the Development of Unconventional IL-17-Producing
Thymocytes
To confirm a cell-intrinsic role for PTEN in the development of IL-17-producing
thymocytes, we generated mixed BM chimeras consisting of congenitally marked
CD45.1+ spike cells and CD45.2+ donor cells from either WT or Cd4crePtenfl/fl mice in a
1:1 ratio. In support of a cell-intrinsic role, only the PTEN-deficient compartment of the
mixed BM chimeras (denoted as CD45.2+ Ptenfl/fl) had enriched IL-17 production
(Figures 4-10A through C). Like in the Cd4crePtenfl/fl mice, the IL-17-producing
thymocytes in the mixed BM chimeras were a heterogeneous population composed of
MAIT17 cells, iNKT17 cells, and other CD1d:PBS57-tet–MR1:5-OP-RU-tet– IL-17producing thymocytes (Figure 4-10D). These data show PTEN restrains the development
of unconventional IL-17-producing thymocytes in a cell-intrinsic manner.
Cellular and Molecular Mechanisms Mediating the Development of Unconventional
IL-17-Producing Thymocytes in Cd4crePtenfl/fl Mice
Cell Survival and Death
Considering that both iNKT and MAIT cell development diverges from
conventional T cells at the DP stage, and that MAIT cells use the most distal segment of
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Figure 4-10. PTEN plays a cell intrinsic role in the development of IL-17producing thymocytes
(A) Flow cytometric analysis of IL-17A production by CD45.2+ WT or Cd4crePtenfl/fl
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the V locus, which means they get selected at the late DP stage (Le Bourhis et al., 2011),
we evaluated the survival of pre- and post-positive selection DP cells. First, we assessed
the transcript levels of Bcl2l1 (Bcl-xL) and Rorc (RORJt), the two master regulators of
lifespan of DP cells (Sun et al., 2000; Wang et al., 2011). Surprisingly, and opposite to
what we expected, both Bcl2l1 and Rorc appeared downregulated in PTEN-deficient prepositive selection DP cells (Figure 4-11A). Within the post-positive selection
compartment, Bcl2l1 transcripts levels were comparable between WT and PTENdeficient DP cells, whereas Rorc was sharply upregulated (Figure 4-11A).
Consistent with decreased transcriptional expression of Bcl2l1 and Rorc at the
pre-positive selection stage of PTEN-deficient DP cells, these cells presented increased
caspase-3 activity as compared to their WT counterparts, and so did the post-positive
selection PTEN-deficient DP cells (Figure 4-11B). These defects in DP cells prompted
us to look at overall cell death in thymus of Cd4crePtenfl/fl mice. No striking differences
were observed among total thymocytes, however (Figure 4-11C). Furthermore, we
evaluated the distribution of cells dying by clonal deletion (CD69highCD5high) or neglect
(CD69lowCD5low) and found no major apparent differences in either group (Figure
4-11C). Altogether, these data suggest the aberrant development of unconventional IL17-producing thymocytes in Cd4crePtenfl/fl mice is not due to enhanced survival of DP
cells during positive selection.
Cell Proliferation
We next investigated the capacity of PTEN-deficient unconventional T cells to
proliferate. To this end, we stained total iNKT cells and MAIT cells with Ki67 and found
no significant difference in iNKT cells, but Ki67 decreased staining in PTEN-deficient
MAIT cells (Figure 4-11D). We further characterized the proliferation status of each
iNKT cell subset and observed a striking decrease in Ki67 staining among PTENdeficient iNKT17 cells, but not in the other subsets (Figure 4-11E). Finally, we
performed overnight in vivo BrdU staining and observed fewer BrdU-incorporated iNKT
cells and MAIT cells among PTEN-deficient thymocytes (Figure 4-11F), suggesting an
overall defect in cell proliferation. Together, these results indicated that the enrichment of
iNKT17 cells and MAIT17 cells in Cd4crePtenfl/fl mice was not due to elevated
proliferation of these thymic subsets. On the contrary, these data suggest PTEN-deficient
unconventional thymic groups have an impaired capacity to proliferate.
mTORC2/FoxO1/RORJJt Signaling Axis
Our lab previously showed mTORC2 signaling plays a crucial role in the
development of iNKT cells and, in particular, fate determination of the type 17 subset
(Wei et al., 2014). Deletion of RICTOR in those studies caused a complete ablation of the
iNKT17 lineage, even in the absence of PTEN, which enhanced iNKT17 generation.
Provided PTEN gets deleted in the T cell lineage of Cd4crePtenfl/fl mice starting at the DP
stage and that it is at the DP stage when iNKT cells and MAIT cells diverge from
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Figure 4-11. Analysis of cell survival and proliferation in Cd4crePtenfl/fl mice.
(A) Relative expression of Bcl2l1 and Rorc in pre- (CD69–TCRE–) and post(CD69+TCRE+) positive selection DP cells of WT and Cd4crePtenfl/fl mice. WT is set to 1.
(B) Active caspase-3 staining in pre- and post-positive selection DP cells of WT and
Cd4crePtenfl/fl mice with frequencies on the right. (C) Active caspase-3 staining in total
thymocytes (left) and identification of cells dying by clonal deletion (CD69highCD5high) or
by neglect (CD69lowCD5low) (right) in WT and Cd4crePtenfl/fl mice. (D and E) Ki67
staining (left) in thymic iNKT and MAIT cells (D) or in thymic iNKT subsets (E) of WT
and Cd4crePtenfl/fl mice with frequencies on the right. (F) In vivo BrdU incorporation in
thymic iNKT and MAIT cells of WT and Cd4crePtenfl/fl mice. Data are means ± SEM. *P
< 0.05, and **P < 0.01. One-tailed unpaired t test (A) and two-tailed Mann-Whitney test
(B, D and E). Data are representative/combination of two (A) or at least three (B-F)
independent experiments. Numbers indicate percentage of cells in gates.
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conventional T cell development, we assessed mTORC2 activity at this critical phase of
T cell development. Consistent with PTEN-mediated regulation of mTORC2 activity, we
found that unstimulated PTEN-deficient DP cells had increased AKT S473
phosphorylation, which is a signature of mTORC2 activity (Figure 4-12A). To evaluate
the involvement of RICTOR/mTORC2 signaling in type 17 unconventional T cell
development in the context of PTEN deficiency, we crossed Cd4crePtenfl/fl mice with mice
carrying loxP-flanked Rictor alleles (Rictorfl/fl). The progeny of these mice
(Cd4crePtenfl/flRictorfl/fl) was deficient for both PTEN and RICTOR in the T cell lineage
compartment. Deletion of RICTOR rescued the enrichment of unconventional IL-17producing thymocytes observed in Cd4crePtenfl/fl mice, an effect that was not restricted to
the iNKT17 cell compartment only (Figures 4-12B, C). Noticeably, RICTOR deficiency
restored the total number of MAIT cells in Cd4crePtenfl/fl mice to WT levels (Figure
4-12D). Therefore, RICTOR-mediated signaling drives the expansion of unconventional
IL-17-producing thymocytes in Cd4crePtenfl/fl mice.
It was recently reported that FoxO1 also controls effector lineage fate decisions of
iNKT cells by promoting iNKT1 but suppressing iNKT17 lineages (Tao et al., 2019).
Furthermore, FoxO1 has been previously described as a T cell-intrinsic inhibitor of the
RORJt+ TH17 differentiation program (Laine et al., 2015) and it is known to be controlled
by AKT-mediated phosphorylation and nuclear exclusion (Chi, 2012). This prompted us
to evaluate FoxO1 signaling as a potential downstream mediator of PTEN/mTORC2dependent control of unconventional IL-17-producing thymocyte development. As
expected, we observed a marked increase in FoxO1 phosphorylation among PTENdeficient DP cells, which was rescued by RICTOR deficiency (Figure 4-13A). Due to the
limited breeding of Cd4creFoxo1fl/fl mice, we generated full BM chimeras from WT and
Cd4creFoxo1fl/fl donors to rapidly expand our colony. We found Cd4creFoxo1fl/fl full BM
chimeras modestly mimicked the phenotype of Cd4crePtenfl/fl mice in that they had a
significantly enriched CCR6+CD127+/IL-17-producing thymocyte population composed
of iNKT cells, MAIT cells, and other CD1d:PBS57-tet–MR1:5-OP-RU-tet– cells (Figures
4-13B, C). Altogether, these results suggest that the involvement of the mTORC2/FoxO1
signaling axis in type 17 fate choices of iNKT cells expands beyond this particular
lineage of unconventional T cells and is conserved among MAIT cells and other
unconventional subsets.
IL-23/STAT3/RORJJt Signaling Axis
The specificity of the phenotype observed in Cd4crePtenfl/fl mice to the type 17
lineage led us to inspect the involvement of molecular players important for IL-17
production and type 17 lineage fate of DE-T cells. IL-6-dependent STAT3 activation is
thought to be crucial for RORJt expression and for the development of TH17 cells
(Durant et al., 2010; Yang et al., 2007). To study the role of STAT3 in the development
of unconventional IL-17-producing thymocytes in the context of PTEN deficiency, we
crossed Cd4crePtenfl/fl mice with mice carrying loxP-flanked Stat3 alleles (Stat3fl/fl). The
progeny of these mice (Cd4crePtenfl/flStat3fl/fl) was, therefore, deficient in PTEN and
STAT3 in their T cell lineage compartment. STAT3 deficiency rescued the accumulation
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Figure 4-12. RICTOR–mediated signaling drives the expansion of unconventional
IL-17-producing thymocytes in Cd4crePtenfl/fl mice.
(A) Flow cytometric analysis of pAKT (S473) in DP (CD4+CD8+) cells of WT and
Cd4crePtenfl/fl mice with MFI plotted in graphs. (B) Flow cytometric analysis of CD127
and CCR6 expression in thymus (top left), along with 5-OP-RU-loaded MR1 tetramer
and PBS57-loaded CD1d tetramer staining of the CCR6+CD127+ thymocyte population
(bottom left) in WT, Cd4crePtenfl/fl, and Cd4crePtenfl/flRictorfl/fl mice. Cellularity of each of
the thymic subsets analyzed is shown (right). (C) Flow cytometric analysis (left) and
cellularity (right) of IL-17-producing thymocytes in WT, Cd4crePtenfl/fl, and
Cd4crePtenfl/flRictorfl/fl mice after ICS stimulation. (D) 5-OP-RU-loaded MR1 tetramer
staining (left) of total thymocytes in WT, Cd4crePtenfl/fl, and Cd4crePtenfl/flRictorfl/fl mice,
along with cellularity (right). Data are means ± SEM. *P < 0.05, **P < 0.01, and ***P <
0.001. One-way (total CCR6+CD127+ population in (B), and (C, D)) or two-way
(CCR6+CD127+ subsets in (B)) ANOVA with Tukey’s test. Data are
representative/combination of four independent experiments. Numbers indicate
percentage of cells in gates or quadrants.
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indicate percentage of cells in gates or quadrants.
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of CCR6+CD127+ cells in Cd4crePtenfl/fl mice, including the various subsets (Figure
4-14A). This effect was further evidenced by the reduction of total IL-17 production
among thymocytes (Figure 4-14B). Similar to RICTOR, the effects of STAT3 deficiency
in the MAIT compartment went beyond just blocking IL-17 production, as the total
number of MAIT cells was returned to WT levels (Figure 4-14C). These results suggest
STAT3 signaling also mediates the accumulation of unconventional IL-17-producing
thymocytes in Cd4crePtenfl/fl mice.
As alluded before, binding of IL-6 to the IL-6R on the cell membrane of T cells
activates STAT3, which then drives transcription of RORJt and other type 17 target
genes. However, studies done by others in our lab revealed IL-6 was dispensable for the
production of IL-17 by PTEN-deficient thymocytes and that so was the transcription
factor RORD (unpublished data). In addition to IL-6, IL-23 also activates STAT3 and
drives the differentiation and stabilization of pathogenic TH17 cells (Gaffen et al., 2014).
Furthermore, in the context of thymic T cell development, IL-23 has been reported to
promote TCR-mediated negative selection of thymocytes by upregulating RORJt and IL23R (Li et al., 2014). Thus, we next assessed the involvement of IL-23 in the generation
of IL-17-producing thymocytes in the absence of PTEN. For this, we crossed
Cd4crePtenfl/fl mice with IL-23-germline deleted mice (Il23–/–) and evaluated the
accumulation of IL-17-producing thymocytes in the progeny (Cd4crePtenfl/flIl23–/–).
Similar to Cd4crePtenfl/flStat3fl/fl mice, Cd4crePtenfl/flIl23–/– largely rescued the
accumulation of PTEN-deficient CCR6+CD127+/IL-17-producing thymocytes, including
the three major subsets identified (Figure 4-15A, B). Interestingly, and consistent with
the effects of RICTOR and STAT3 deficiency, absence of IL-23 not only blocked IL-17
production by MAIT cells, but also prevented their overall accumulation (Figure 4-15C).
Altogether, these results suggest that the IL-23/STAT3/RORJt signaling axis,
independently of IL-6 and RORD, drive the development and accumulation of
unconventional IL-17-producing thymocytes in the absence of PTEN.
Summary
In this chapter, we explored the role of PTEN in the development of TCRDE+
cells. To circumvent the tumorigenic effects of PTEN deletion in the T cell compartment,
we analyzed mice younger than 6 weeks of age, which showed no signs of tumorigenesis
and presented relatively normal DE-T cell development. Unexpectedly, we found deletion
of PTEN at the DP stage of DE-T cell development caused an enrichment of IL-17producing lymphocytes that were restricted to the thymus. Interestingly, the PTENdeficient IL-17-producing thymocytes were not conventional nTH17 cells but rather
constituted a heterogeneous population composed of iNKT17 cells, MAIT17 cells, and
other unconventional T cell populations. As shown by the mixed BM chimera
experiments, the effects of PTEN deficiency in the development and accumulation of
unconventional IL-17-producing thymocytes were cell-intrinsic. Furthermore, the
accumulation of PTEN-deficient IL-17-producing thymocytes was independent of prepositive selection survival and post-positive selection proliferation. On the contrary,
PTEN-deficient pre-positive selection DP cells had increased caspase-3 activity, an
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Figure 4-14. STAT3 deficiency rescues the accumulation of unconventional IL-17producing thymocytes in the context of PTEN deficiency.
(A) Flow cytometric analysis of CD127 and CCR6 expression in thymus (top left), along
with 5-OP-RU-loaded MR1 tetramer and PBS57-loaded CD1d tetramer staining of the
CCR6+CD127+ thymocyte population (bottom left) in WT, Cd4crePtenfl/fl, and
Cd4crePtenfl/flStat3fl/fl mice. Cellularity of each of the thymic subsets analyzed is shown
(right). (B) Flow cytometric analysis (left) and cellularity (right) of IL-17-producing
thymocytes in WT, Cd4crePtenfl/fl, and Cd4crePtenfl/flStat3fl/fl mice after ICS stimulation.
(C) 5-OP-RU-loaded MR1 tetramer staining (left) in total thymocytes of WT,
Cd4crePtenfl/fl, and Cd4crePtenfl/flRictorfl/fl mice, along with cellularity (right). Data are
means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. One-way
(total CCR6+CD127+ population in (A), and (B, C)) or two-way (CCR6+CD127+ subsets
in (A)) ANOVA with Tukey’s test. Data are representative of three independent
experiments. Numbers indicate percentage of cells in gates or quadrants.
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Figure 4-15. IL-23 deficiency rescues the accumulation of unconventional IL-17producing thymocytes in the context of PTEN deficiency.
(A) Flow cytometric analysis of CD127 and CCR6 expression in thymus (top left), along
with 5-OP-RU-loaded MR1 tetramer and PBS57-loaded CD1d tetramer staining of the
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(right). (B) Flow cytometric analysis (left) and cellularity (right) of IL-17-producing
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indicator of apoptosis, and both PTEN-deficient iNKT17 cells and MAIT17 cells had
reduced proliferation. Studies on the molecular mechanisms associated with the
accumulation of IL-17-producing thymocytes in the context of PTEN deficiency revealed
that both the RICTOR/FoxO1 and the IL-23/STAT3 signaling pathways converged to
drive RORJt-dependent development of type 17 unconventional T cells. Based on studies
done by others in our lab, this aforementioned molecular control was independent of the
cytokine IL-6 and the transcription factor RORD (unpublished data). Altogether, these
results reveal PTEN acts as a cell-intrinsic molecular brake for the development of
unconventional IL-17-producing thymocytes.
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coding at the top of the next page.
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CHAPTER 5.

DISCUSSION3

Unconventional T cells have emerging roles in tissue homeostasis and disease
(Iwabuchi and Van Kaer, 2019). Their conserved nature among mammals highlights the
importance of these unique T cell populations in the immune system (Moreira et al.,
2017). However, we are just now beginning to elucidate the molecular mechanisms
mediating their development and fate decisions (Godfrey et al., 2015; Lantz and Legoux,
2019). Despite recent advances in the field of immunometabolism, it remains largely
unknown what role metabolic signals play in T cell lineage decisions and, in particular, in
the development of unconventional T cells. Our studies revealed that RAPTOR/mTORC1
signaling dictates the lineage choices of DE and JG-T cells by integrating metabolic
activities and TCR signaling strength in developing T cells. Furthermore, we identified
mTORC1-dependent control of ROS production as a key metabolic signal in this process
and unraveled PTEN as a cell-intrinsic molecular brake for the development and
accumulation of type 17 unconventional thymocytes. Altogether, our results point to
metabolic processes and signaling as fundamental mechanisms that connect extrinsic
stimuli with transcriptional events and T cell fate decisions.
An extensive body of literature highlights the role of metabolic reprogramming in
controlling T cell-mediated immune responses (Chapman et al., 2020; Pearce et al., 2013;
Pollizzi and Powell, 2014). Although NOTCH and IL-7 signaling have been shown to
exert trophic effects in T cell development, little is known about the metabolic programs
underpinning thymocyte development (Boudil et al., 2015; Ciofani and Zuniga-Pflucker,
2005). Noticeably, the adaptive immune system is characterized by the fluctuation and
intertwining of cycles of quiescence and activation that accompany the developmental
and functional progression of T lymphocytes throughout their lifespan (Chapman et al.,
2020). Largely nondividing progenitor cells colonize the thymus, which later undergo
two waves of proliferation separated by a brief period of quiescence required for TCREchain rearrangement at the DN3 stage (Carpenter and Bosselut, 2010). Upon arrival to the
DP stage, developing thymocytes return to quiescence to undergo TCRD-chain
rearrangement. Metabolic assessment of thymocyte populations revealed that DN3 and
DP cells preferentially use OXPHOS, consistent with their quiescent state, whereas DN4
and ISP cells engage anabolic programs in association with their robust expansion.
Moreover, we found that DN3 cells have a greater SRC in comparison to other thymic
subsets, indicating that they have stronger mitochondrial capacity to produce energy in
response to stress. The use of distinct metabolic programs by developing thymocytes
likely fulfills the bioenergetic demands and signaling requirements of the underlying
developmental processes. Importantly, these dynamic metabolic programs are associated
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with differential regulation of mTORC1 activity, suggesting a role for mTORC1dependent control of metabolic reprogramming during T cell development.
Recent studies have highlighted the role of mTOR in thymocyte development
(Hoshii et al., 2014; Lee et al., 2012; Tang et al., 2012). However, the involvement of
mTORC1 signaling in DE and JG-T cell lineage choices had remained unexplored. Using
genetic deletion of RAPTOR, our studies revealed that RAPTOR-dependent mTORC1 is
a crucial mediator of T cell development and lineage choices. Loss of RAPTOR impaired
DE but promoted JG-T cell development. Our studies using mixed BM chimeras and the
OP9-DL1 cell coculture system demonstrated that this effect occurred in a cell-intrinsic
manner. Additionally, RAPTOR-deficient JG-T cells expressed high levels of CD73, a
marker that has been linked to TCRJG+ lineage commitment (Coffey et al., 2014), further
supporting a role for RAPTOR in limiting JG-T cell development.
The RAPTOR-dependent mTOR control of JG-T cell development was
independent of RICTOR, as RICTOR-deficient thymocytes presented no defects in
lineage choices. However, concomitant deletion of RAPTOR and RICTOR further
exacerbated the altered development of DE and JG-T cells. This genetic redundancy of
mTORC1 and mTORC2 in T cell development was unique and distinct from their
relationship in peripheral T cells, in which additional loss of RICTOR either ameliorates
or has little impact on the phenotypes caused by RAPTOR deficiency (Yang et al., 2013;
Zeng et al., 2013). These findings highlight the predominant role of RAPTOR-dependent
mTORC1 signaling in T cell lineage commitment.
Considering that RAPTOR-deficient DN3 cells presented defective glycolytic rate
and faulty OCR/ECAR balance, our data suggested that RAPTOR-dependent mTORC1
activation and metabolic reprogramming drove quiescence exit of DN3 cells.
Additionally, RAPTOR-deficient thymocytes were less efficient in undergoing
population expansion, especially during the ISP stage. Given the intricate relationship
between cell proliferation and differentiation (Kreslavsky et al., 2012), such proliferative
defect likely contributed to the developmental blockade and accumulation of ISP cells in
Cd2creRptorfl/fl mice. These results suggest that RAPTOR-dependent metabolic
reprogramming and quiescence exit are fundamental determinants of population
expansion and lineage specification in thymocyte development.
The disruption of anabolic metabolism by genetic ablation of RAPTOR resulted
in dysregulated ROS production. The elevated levels of ROS in RAPTOR-deficient
thymocytes impinged upon their fate decisions as antioxidant treatment of these cells
rescued, albeit incompletely, their differentiation defect. Furthermore, and similarly to the
RAPTOR-associated phenotypes, pharmacological perturbation of redox homeostasis in
WT thymocytes impinged upon their fate decisions. In fact, either boosting or reducing
ROS production in DN3 cells had a direct impact on their fate choices toward DE or JG-T
cell lineages. These results reveal a selective role for redox regulation in mediating cell
fate decisions downstream of the multifunctional kinase mTORC1 and show that
metabolic signaling is a decisive factor in the fate decisions of DE and JG-T cells during
thymic development.
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The development of DE and JG-T cells is contingent upon the fate decisions of a
common bipotent thymocyte progenitor, namely the DN3 cells. TCR signaling strength
has emerged as an instructional signal that determines T cell lineage fate decisions of
uncommitted precursors (Haks et al., 2005; Hayes et al., 2005; Lee et al., 2014; Zarin et
al., 2014). Specifically, the ERK/EGR1/ID3 signaling axis is now recognized to play a
crucial role in this process, in such a way that strong signals promote the development of
JG-T cells, whereas weak signals facilitate DE-T cell development (Haks et al., 2005;
Hayes et al., 2005). What regulates the strength of these TCR signals has remained
elusive, however. We found that loss of RAPTOR markedly promoted the activation of
ERK, EGR1, and ID3 in DN3 cells, and that this effect was associated with increased
development of lineage-committed JG-T cells. Additionally, increased ROS production
by WT DN3 cells resulted in increased ID3 and CD73 expression. Collectively, our
results suggest that mTORC1 activity and ROS metabolism impinge on the activity of the
ERK/EGR1/ID3 signaling axis, therefore, influencing TCR signaling strength and the
subsequent lineage choices of DN3 cells (Figure 5-1).
As an upstream regulator of mTOR, PTEN governs multiple cellular processes,
including survival, proliferation, energy metabolism, and cellular architecture (Song et
al., 2012). Selective deletion of PTEN in T cells induces the development of fatal T cell
lymphomas along with the establishment of autoimmune disorders (Liu et al., 2010b;
Suzuki et al., 2001). As our work with Cd4crePtenfl/fl mice confirmed, before the onset of
tumorigenesis in PTEN-deficient mice, thymocyte development proceeds largely normal
with unchanged cellularity or distribution of major thymic subsets (Buckler et al., 2006).
However, as our studies revealed, PTEN deficiency in developing thymocytes causes the
accumulation of unconventional thymic-resident IL-17-producing lymphocytes.
In addition to the unconventional TCRJG+ T cell lineage, there are also TCRDE+ T
cells that have an unconventional development and innate-like phenotype (Godfrey et al.,
2015). Such unconventional lymphocytes have a limited TCR repertoire and present
innate-like effector functions (Pasman and Kasper, 2017). Due to their prevalence in
mice, iNKT cells are the most well-studied type of unconventional DE-T cells (Garner et
al., 2018). However, the recent development of MR1 tetramers for the easy identification
of MAIT cells (Rahimpour et al., 2015), along with their strong predominance in humans
(Lantz and Legoux, 2018), has promoted an emerging interest in this unconventional
population. Interestingly, the enrichment of IL-17-producing thymocytes in Cd4crePtenfl/fl
mice was mediated by the accumulation of a heterogeneous population of iNKT17 cells,
MAIT17 cells, and a third CD1d:PBS57-tet–MR1:5-OP-RU-tet– population.
Phenotypic characterization of PTEN-deficient IL-17-producing thymocytes
showed that the MAIT compartment was composed of fully mature MAIT17 cells, which
had a transcriptional profile that resembled that of their iNKT17 counterparts. The
CD1d:PBS57-tet–MR1:5-OP-RU-tet– population, however, had a markedly distinct
transcriptome and presented further heterogeneity. In particular, we were able to identify
at least three populations of T cells within the CD1d:PBS57-tet–MR1:5-OP-RU-tet–
fraction of the PTEN-deficient IL-17-producing thymocytes. These were Tc17 cells,
CD8DD+ IEL-like precursors (both CD8DD+ and TP), and a previously uncharacterized
79

Figure 5-1. Schematic of RAPTOR/mTORC1-mediated control of metabolic
remodeling, redox homeostasis, and TCR signal strength in T cell lineage choices.
Activation of mTORC1 by TCR and NOTCH signaling orchestrates cellular metabolism
of developing thymocytes. Dynamic metabolic remodeling, including the proper balance
between OXPHOS and glycolysis, contributes to anabolism and cell expansion.
However, dysregulated metabolism results in aberrant ROS production, which alters
redox balance and impinges upon TCR signaling strength, thereby altering lineage
choices of DE and JG-T cells.
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thymic population of IL-17-producing CD4–CD8– DN cells that expressed high levels of
CD5, PD-1, and Sca-1, but not CD122. These results suggest a conserved mechanism
controlled by PTEN for the development of type 17 unconventional T cells.
Recent studies have highlighted the role microbial metabolites play in controlling
the thymic development of MAIT cells (Constantinides et al., 2019; Legoux et al.,
2019a). These studies have shown that microbiota-derived metabolites are indispensable
for the development of MAIT cells and that they act as cell-extrinsic facilitators of this
process. Our studies done in the context of mixed BM chimeras indicated that PTEN acts
as a cell-intrinsic negative regulator of the development and accumulation of IL-17producing thymocytes, including MAIT17 cells. Therefore, our data highlights a second
level of regulation for the development of MAIT cells that is cell-intrinsic.
PTEN has previously been shown to be an important regulator of proliferation of
developing thymocytes, as loss of PTEN allows TCRDE-lineage thymocytes to bypass
IL-7 and pre-TCR-mediated signaling in LckcrePtenfl/fl mice (Hagenbeek et al., 2004).
However, our studies in Cd4crePtenfl/fl mice revealed pre-positive selection DP cells had
reduced transcriptional expression of master regulators of DP survival, namely Bcl2l1
(Bcl-xL) and Rorc (RORJt), and, consequently, increased apoptosis. PTEN-deficient postpositive selection DP cells had markedly increased Rorc expression but, consistent with
the literature (He et al., 2000), this effect did not translate to enhanced lifespan of these
thymocytes. Furthermore, we found defective, not enhanced, proliferation among postselection iNKT17 cells and MAIT cells. These results suggest PTEN plays a role in the
development of innate-like IL-17-producing thymocytes that is independent of prepositive selection survival or post-positive selection proliferation.
We next investigated molecular players downstream of PTEN mediating the
development of unconventional IL-17-producing thymocytes. Consistent with previous
findings from our lab (Wei et al., 2014), deletion of RICTOR caused a complete ablation
of the iNKT17 lineage. Moreover, we found RICTOR was important for the development
of all type 17 unconventional T cell populations, not just for the iNKT17 lineage. Our
data suggested that this effect was mediated by FoxO1 signaling, consistent with
evidence in the literature that FoxO1 suppresses the development of iNKT17 cells (Tao et
al., 2019) and acts as a T cell-intrinsic inhibitor of RORJt+ TH17 differentiation (Laine et
al., 2015). Altogether, these results indicate a central role for the mTORC2/FoxO1
signaling axis in the activation of RORJt that drives the development of PTEN-deficient
type 17 unconventional T cells.
In addition to the RICTOR/FoxO1/RORJt signaling pathway, which is known to
be downstream of PTEN, we also assessed the involvement of other molecular players
upstream of RORJt in the development of PTEN-deficient IL-17-producing thymocytes.
In particular, we found STAT3 and IL-23 to be essential in the generation of type 17
unconventional thymocytes in the context of PTEN deficiency. Phosphorylation of
STAT3 monomers drive their dimerization and translocation to the nucleus, where they
mediate the transcription of the transcription factors RORJt and RORD and the cytokines
IL-17A, IL-17F, IL-21, and IL-23 (Tripathi et al., 2017; Wang et al., 2013b). The
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cytokines IL-6 and IL-23 are known activators of STAT3 signaling (Rebe et al., 2013).
Interestingly, experiments done by others in our lab showed that IL-6 and RORD were
dispensable for the generation of PTEN-deficient unconventional IL-17-producing
thymocytes (unpublished data). Remarkably, deletion of either STAT3 or IL-23 in the
context of PTEN-deficiency not only rescued the overproduction of IL-17, but also
prevented the total accumulation of MAIT cells. These results suggest that the capacity of
PTEN-deficient thymocytes to develop as unconventional T cells is contingent upon the
activation of the IL-23/STAT3 signaling pathway.
The acquisition of innate-like effector function by unconventional T cells is
dependent on the transcription factor PLZF (Cao et al., 2018). Our gene expression
analyses showed that the PTEN-deficient IL-17-producing thymocytes had elevated
PLZF activity. Studies in iNKT cells have shown RAPTOR-deficient iNKT cells have
reduced nuclear localization of PLZF, suggesting mTORC1 promotes PLZF nuclear
localization and, thereby, its activity (Yang et al., 2015). Considering the high
transcriptional similarity between iNKT17 cells and MAIT17 cells, and that these
unconventional lymphocytes constituted a significant fragment of the total PTENdeficient IL-17-producing thymocyte population, it is possible that a similar mechanism
of regulation occurs in the context of PTEN deficiency. However, transcriptional
regulation of PLZF remained unexplored in our studies. Future work is warranted to
understand the relationship between PLZF and RORJt, along with the RICTOR/FoxO1
and IL-23/STAT3 signaling pathways, in driving the development of type 17
unconventional T cells (Figure 5-2). Furthermore, it will be important to assess the
physiological consequences of the accumulation of IL-17-producing thymocytes,
especially as it concerns to thymic structure and medullary region homeostasis, which are
disrupted in PTEN-deficient mice before the onset of disease (data not shown).
In summary, our studies revealed that thymocyte development is closely linked to
dynamic regulation of metabolic programs, mTORC1 activity, and redox homeostasis,
which together impinge upon T cell lineage commitment. Furthermore, we found that the
tumor-suppressor PTEN is a cell-intrinsic negative regulator of the development of
TCRDE+ unconventional IL-17-producing thymocytes. Collectively, our studies establish
mTORC1 signaling as a developmental checkpoint that links intrathymic environmental
signals and metabolic programs to drive thymocyte development, and PTEN as a
molecular brake for the development and accumulation of thymic-resident type 17 innatelike T cells. Future studies shall further dissect the cell context-dependent regulation and
physiological effects of metabolic and redox controls in immune cell development and
activation, particularly in the context of unconventional T cells.
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Figure 5-2. Schematic of PTEN-mediated control of the development of
unconventional IL-17-producing thymocytes.
Recognition of cognate antigen by TCR, along with ICOS costimulation, signals through
RICTOR/mTORC2, which phosphorylates AKT. AKT, in turn, inhibits nuclear
translocation of FoxO1 by phosphorylating it, and nuclear FoxO1 blocks RORJtmediated transcription of IL-17. This process is controlled by the lipid phosphatase
PTEN, which opposes PI3K-dependent phosphorylation of PIP2 and, therefore, activation
of RICTOR/mTORC2. In parallel, engagement of IL-23 by the IL-23R, along with IL-7
stimulation, induces phosphorylation of STAT3 monomers, which allows for their
dimerization and subsequent nuclear localization. In the nucleus, STAT3 mediates
transcription of RORJt and the IL-17 family of cytokines. PLZF mediates the acquisition
of innate-like features by unconventional T cells. However, the interrelation between
PLZF and RORJt, along with the other molecular players identified, requires further
investigation.
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